Acknowledgements 2017 Annual Report

Table of Contents

PAGE 2 PAGE 6 PAGE 6 Research Partnerships Advisors Grants

PAGE 7 PAGE 10 PAGE 20 2017 National Donors Legacy Circle Recognition & Awards Program

PAGE 20 PAGE 21 PAGE 22 Research Endowment Leadership Portfolios Funds 2 THE LEUKEMIA & LYMPHOMA SOCIETY

Research Grants

David Weinstock, MD, 2016 Omar Abdel-Wahab, MD, 2017 Irene Ghobrial, MD, 2017 Specialized Dana-Farber Cancer Institute Memorial Sloan Kettering Cancer Dana-Farber Cancer Institute Center Center of Research Anas Younes, MD, 2017 Jolanta Grembecka, PhD, 2014 Memorial Sloan Kettering Cancer Saro Armenian, DO, MPH, 2017 University of Michigan The Specialized Center of Research Center Beckman Research Institute of Program funds multidisciplinary David Guertin, PhD, 2016 City of Hope research by teams of leading-edge Dr. Anas Younes is funded in part University of Massachusetts Medical academic investigators that hastens by Patrick Allender, C.E. and Jean Uttiya Basu, PhD, 2016 School Andrews, Dr. Evelyn Bata, Beltway Columbia University Medical Center the discovery and development Katharine Hsu, MD, PhD, 2017 Cleaning Services, Valorie and of better treatments for leukemia, Julie Blander, PhD, 2015 Memorial Sloan Kettering Cancer Melvin Booth, Cynthia and Joe lymphoma and myeloma patients. A Weill Cornell Medical College Center center is comprised of at least three Bruno, Danielle D’Aiello, Danaher independent research programs Corporation, The Irwin and Ginny Robert Bradley, MD, 2018* Morgan Huse, PhD, 2015 that are integrated and supported Edlavitch Foundation, LIUNA Fred Hutchinson Cancer Research Memorial Sloan Kettering Cancer by scientific core laboratories. Charitable Foundation, Al and Center Center Suzanne Lord, the J. Willard and Jan Burger, MD, PhD, 2014 Peng Ji, MD, PhD, 2018* William Carroll, MD, 2014 Alice S. Marriott Foundation, Cynthia The University of Texas MD Northwestern University New York University School of and Daniel Johnson, Caren and Anderson Cancer Center Medicine Phillip Merrick, Nancy and Patrick Amy Johnson, PhD, 2018* Minan, Beverly and Stephen Movius, Dr. Jan Burger is funded in part by The Ohio State University Dr. William Carroll is funded in part Wendy and Mike O’Neil, Jim and David Weinstein. by Thomas Moore. Michael Kharas, PhD, 2018* Gail Palmer, Kathleen and Edward Memorial Sloan Kettering Cancer Fernando Camargo, PhD, 2016 Irene Ghobrial, MD, 2014 Quinn, the Starfish Foundation, Center Virginia Sheldon Jerome Boston Children’s Hospital Dana-Farber Cancer Institute John Koreth, MD, PhD, 2014 Foundation, and The William J. Jianjun Chen, PhD, 2018* Dana-Farber Cancer Institute Helen Heslop, MD, 2014 Shaw Family Foundation. University of Cincinnati Baylor College of Medicine Ming Li, PhD, 2015 Dr. Jianjun Chen is fully funded The following SCOR grant funding Memorial Sloan Kettering Cancer Carl June, MD, 2013 by The Marge & Charles Schott University of Pennsylvania Health ended during FY17 and was funded, Center in part or full, by a donor: Foundation. System Ivan Maillard, MD, PhD, 2014 Dr. Carl June is funded in part by the • Dr. John Byrd was funded in part Jerry Chipuk, PhD, 2017 University of Michigan Icahn School of Medicine at Mount Cora and John H. Davis Foundation, by Rita Cavanaugh and Gerald Ravindra Majeti, MD, PhD, 2016 Sinai the Topeka Community Foundation Kafka. Leland Stanford Junior University - Advisors Excel Team and an anon- Dipanjan Chowdhury, PhD, 2015 Constantine Mitsiades, MD, PhD, ymous donor. • Dr. Jonathan Licht was funded Dana-Farber Cancer Institute in part by the Kathryn Dent and 2017 Thomas Kipps, MD, PhD, 2014 John L. Tillman Charitable Fund. Tomasz Cierpicki, PhD, 2017 Dana-Farber Cancer Institute University of Michigan University of California, San Diego Golam Mohi, PhD, 2014 Tak Mak, PhD, 2017 Dr. Tomasz Cierpicki is fully funded SUNY Upstate Medical University by The Jake Wetchler Foundation. University Health Network Career Development Ann Mullally, MD, 2018* Ari Melnick, MD, 2016 Program (Scholars and Takeshi Egawa, MD, PhD, 2018* Brigham and Women’s Hospital Weill Cornell Medical College Clinical Scholars) Washington University School of Trista North, PhD, 2017 Stephen Nimer, MD, 2018* Medicine in St. Louis Beth Israel Deaconess Medical University of Miami The Career Development Program Thomas Fazzio, PhD, 2015 Center provides stipends to investigators Robert Orlowski, MD, PhD, 2018* University of Massachusetts Medical Ryan O’Connell, PhD, 2018* of exceptional promise in the early The University of Texas MD School University of Utah stages of their careers, helping Anderson Cancer Center them devote their careers to Benjamin Garcia, PhD, 2016 Ryoma Ohi, PhD, 2014 Andreas Strasser, MSc, FAA, PhD, research in leukemia, lymphoma or Perelman School of Medicine at the Vanderbilt University Medical Center University of Pennsylvania 2018* myeloma. Sophie Paczesny, MD, PhD, 2015 Walter & Eliza Hall Institute of Ramiro Garzon, MD, 2016 Indiana University Medical Research The Ohio State University

*Newly awarded or renewed grants in Fiscal Year 2018 2017 ACKNOWLEDGEMENTS 3

Christopher Park, MD, PhD, 2018* Hans-Guido Wendel, MD, 2015 Dan Dominissini, PhD, 2016 Vera Mugoni, PhD, 2016 New York University School of Memorial Sloan Kettering Cancer The University of Chicago Beth Israel Deaconess Medical Medicine Center Center Shannon Elf, PhD, 2018* Talya Salz, PhD, 2014 Dr. Hans-Guido Wendel is funded in Brigham and Women’s Hospital Shannon Oda, PhD, 2018* Memorial Sloan Kettering Cancer part by Susan Reid. Fred Hutchinson Cancer Research Jonathan Esensten, MD, PhD, 2017 Center Center University of California, San Johnathan Whetstine, PhD, 2015 Joseph Scandura, MD, PhD, 2014 Francisco Dr. Shannon Oda is fully funded by Massachusetts General Hospital Weill Cornell Medical College Dr. Dhaval Dhru. Dr. Jonathan Esensten is funded in Catherine Wu, MD, 2015 Xiaobing Shi, PhD, 2017 part by an anonymous donor. Dana-Farber Cancer Institute Tamara Ouspenskaia, PhD, 2018* The University of Texas MD Broad Institute Anderson Cancer Center Xiaochun Yu, MD, PhD, 2015 Craig Forester, MD, PhD, 2016 Beckman Research Institute of University of California, San Jelena Petrovic, PhD, 2017 Daniel Starczynowski, PhD, 2016 City of Hope Francisco University of Pennsylvania Health Cincinnati Children’s Hospital System Medical Center Shan Zha, MD, PhD, 2014 Jennifer Grants, PhD, 2018* Columbia University Medical Center British Columbia Cancer Agency Lars Plate, PhD, 2016 Kimberly Stegmaier, MD, 2014 The Scripps Research Institute Dana-Farber Cancer Institute Chengcheng Zhang, PhD, 2014 Bingqian Guo, PhD, 2018* The University of Texas Harvard Medical School Russell Ryan, MD, 2017 Ulrich Steidl, MD, PhD, 2015 Southwestern Medical Center Massachusetts General Hospital Albert Einstein College of Medicine Sarah Hainer, PhD, 2017 Jing Zhang, PhD, 2014 University of Massachusetts Medical Prabha Sarangi, PhD, 2016 Enrico Tiacci, MD, 2014 University of Wisconsin School Dana-Farber Cancer Institute University of Perugia Xiaolan Zhao, PhD, 2014 Lulu Hu, PhD, 2018* Anne Schuetz, PhD, 2017 Raoul Tibes, MD, PhD, 2015 Memorial Sloan Kettering Cancer The University of Chicago University of Toronto Mayo Clinic, Arizona Center Daichi Inoue, MD, PhD, 2018* Ashima Shukla, PhD, 2018* Wei Tong, PhD, 2014 Memorial Sloan Kettering Cancer Sanford Burnham Prebys Medical Children’s Hospital of Philadelphia Center Discovery Institute Dr. Tong was funded in part by The Career Development Andrew Intlekofer, MD, PhD, 2016 Vipul Shukla, PhD, 2018* VWR Foundation. Program (Special Memorial Sloan Kettering Cancer La Jolla Institute for Allergy and Fellows, Clinical Center Immunology Saad Usmani, MD, 2018* Charlotte Mecklenburg Hospital Special Fellows and Neeraj Joshi, MSc, PhD, 2016 Eric Smith, MD, PhD, 2018* Authority (Carolinas HealthCare Fellows) University of California, San Memorial Sloan Kettering Cancer System) Francisco Center Shruti Bhatt, PhD, 2017 Dr. Saad Usmani is funded in Yoon-A Kang, PhD, 2018* Srividya Swaminathan, PhD, 2017 Dana-Farber Cancer Institute part by the Carolinas Healthcare Columbia University Medical Center Leland Stanford Junior University Foundation. George Burslem, MS, PhD, 2018* Richard Jason Lamontagne, PhD, Dr. Srividya Swaminathan is funded Yale University 2018* in part by an anonymous donor. Geoffrey Uy, MD, 2018* Sheng F. Cai, MD, PhD, 2017 The Wistar Institute Washington University in St. Louis Memorial Sloan Kettering Cancer Elisa ten Hacken, PhD, 2018* Fides Lay, PhD, 2017 Christopher Vakoc, MD, PhD, 2016 Center Dana-Farber Cancer Institute University of California, Los Angeles Cold Spring Harbor Laboratory Hye Ji Cha, PhD, 2017 Rachel Thijssen, PhD, 2018* I-Ju Lee, PhD, 2016 Loren Walensky, MD, PhD, 2015 Boston Children’s Hospital Walter & Eliza Hall Institute of Dana-Farber Cancer Institute Dana-Farber Cancer Institute Medical Research Huan Chen, PhD, 2017 Stanley Lee, PhD, 2017 Matthew Walter, MD, 2014 Boston Children’s Hospital Zuzana Tothova, MD, PhD, 2016 Memorial Sloan Kettering Cancer Washington University School of Dana-Farber Cancer Institute Ryan Corces, PhD, 2018* Center Medicine in St. Louis Leland Stanford Junior University Peter van Galen, PhD, 2017 Dr. Stanley Lee is funded in part by Roland Walter, MD, PhD, MS, 2015 Massachusetts General Hospital Ahmet Coskun, PhD, 2016 an anonymous donor. Fred Hutchinson Cancer Research Leland Stanford Junior University Leandro Venturutti, PhD, 2018* Center Qiming Liang, PhD, 2016 Weill Cornell Medical College Madzia Crossley, PhD, 2017 Dr. Roland Walter is fully funded by Shanghai Institute of Immunology Leland Stanford Junior University Matthew Witkowski, PhD, 2018* Dr. Dhaval Dhru. Ruiting Lin, PhD, 2018* New York University School of Ana Carolina da Silva Almeida, PhD, Emory University Medicine Wenyi Wei, PhD, 2014 2017 Beth Israel Deaconess Medical Columbia University Medical Center Priya Mathur, PhD, 2018* Bas Wouters, MD, PhD, 2016 Center The University of Chicago Erasmus University Rotterdam Sarah Deng, PhD, 2017 David Weinstock, MD, 2014 New York University Medical Center Lucia Morgado Palacin, PhD, 2018* Selwin Wu, PhD, 2017 Dana-Farber Cancer Institute Columbia University Medical Center Dana-Farber Cancer Institute

*Newly awarded or renewed grants in Fiscal Year 2018 4 THE LEUKEMIA & LYMPHOMA SOCIETY

Heping Xu, PhD, 2016 Carl Allen, MD, 2018* Adolfo Ferrando, MD, PhD, 2018* Larry Kwak, MD, PhD, 2018* Cincinnati Children’s Research Baylor College of Medicine Columbia University Medical Center Beckman Research Institute of City Foundation of Hope Stephen Ansell, MD, PhD, 2018* Dr. Adolfo Ferrando is funded in part Dongqing Yan, PhD, 2018* Mayo Clinic, Rochester by The Higgins Foundation. Dan Landau, MD, PhD, 2017 The University of Utah Weill Cornell Medical College Dr. Stephen Ansell is fully funded by Andrés Ferreri, MD, 2017 Chao Yang, PhD, 2016 an anonymous donor. Ronald Levy, MD, 2018* Fondazione Centro San Raffaele The Johns Hopkins University Leland Stanford Junior University School of Medicine Caroline Arber, MD, 2016 Mark Frattini, MD, PhD, 2015 Timothy Ley, MD, 2018* Baylor College of Medicine Columbia University Medical Center Noemi Zambetti, PhD, 2018* Washington University School of University of California, San Fotis Asimakopoulos, MB Bchir, PhD, Dr. Mark Frattini is funded in part by Medicine in St. Louis Francisco 2018* The Stephen Birnbaum Foundation. William Matsui, MD, 2016 University of Wisconsin Yu Zhang, PhD, 2018* Karin Gaensler, MD, 2018* The Johns Hopkins University Jon Aster, MD, PhD, 2018* Boston Children’s Hospital University of California, San School of Medicine Brigham and Women’s Hospital Hufeng Zhou, PhD, 2016 Francisco Dr. William Matsui is funded in part Francesco Bertoni, MD, 2017 Brigham and Women’s Hospital Jacqueline Garcia, MD, 2018* by The Charles T. Bauer Charitable Fondazione per la Ricerca e la Cura Foundation. Jiajun Zhu, PhD, 2018* Dana-Farber Cancer Institute dei Linfomi nel Ticino Memorial Sloan Kettering Cancer Lucy Godley, MD, PhD, 2017 Constantine Mitsiades, MD, PhD, Center Ranjit Bindra, MD, PhD, 2018* The University of Chicago 2018* Yale University Stephen Gottschalk, MD, 2016 Dana-Farber Cancer Institute Bruce Blazar, MD, 2018* The following CDP grant funding Baylor College of Medicine Charles Mullighan, MD, MBBS, 2017 University of Minnesota Twin Cities ended during FY17 and was funded, Douglas Graham, MD, PhD, 2016 St. Jude Children’s Research Marie Bleakley, MD, PhD, 2017 in part or full, by a donor: Emory University Hospital Fred Hutchinson Cancer Research Nikhil Munshi, MD, 2016 • Dr. Christopher Cogle was funded Center Dr. Douglas Graham is funded in Dana-Farber Cancer Institute in part by the Kathryn Dent and part by the Melody Cronin Fund. Mario Boccadoro, MD, 2016 John L. Tillman Charitable Fund. Stephen Nimer, MD, 2018* Università degli Studi di Torino Steven Grant, MD, 2015 University of Miami • Dr. Irene Ghobrial was funded Giulia Casorati, PhD, 2016 Virginia Commonwealth University Teresa Palomero, PhD, 2017 in part by the Kathryn Dent and Fondazione Centro San Raffaele Dr. Steven Grant is funded in part by Columbia University Medical Center John L. Tillman Charitable Fund. Leandro Cerchietti, MD, 2016 the Breeden-Adams Foundation. Jae Park, MD, 2018* Weill Cornell Medical College • Dr. Saad Usmani was funded in Jolanta Grembecka, PhD, 2016 Memorial Sloan Kettering Cancer part by the Carolinas Healthcare Li Chai, MD, 2016 University of Michigan Center Foundation. Brigham and Women’s Hospital Edwin Hawkins, PhD, 2018* Jun Qi, PhD, 2018* George Daley, MD, PhD, 2018* Walter & Eliza Hall Institute of Dana-Farber Cancer Institute Boston Children’s Hospital Medical Research Noopur Raje, MD, 2017 Translational Research Alexey Danilov, MD, PhD, 2018* Timothy Hughes, MD, FRACP, Massachusetts General Hospital Oregon Health & Science University Program FRCPA, MBBS, 2017 Dr. Noopur Raje is funded in part by Hema Dave, MD, MPH, 2018* South Australian Health & Medical an anonymous donor. The Translational Research Program Children’s Research Institute Research Institute supports outstanding investigators Feyruz Rassool, PhD, 2016 deemed by our expert advisors Sandeep Dave, MD, MS, 2016 Emmanuel Katsanis, MD, 2017 University of Maryland at Baltimore most likely to translate basic bio- Duke University Medical Center The University of Arizona medical discoveries into new, safe Katy Rezvani, MD, PhD, 2018* Kara Davis, DO, 2018* Michael Kharas, PhD, 2017 and effective treatments, ultimately The University of Texas Leland Stanford Junior University Memorial Sloan Kettering Cancer prolonging and enhancing patients’ Center MD Anderson Cancer Center Randall Davis, MD, 2017 lives. Alain Rook, MD, 2016 The University of Alabama at Yong-Mi Kim, MD, PhD, MPH, 2017 University of Pennsylvania Health Ricardo Aguiar, MD, PhD, 2017 Birmingham Children’s Hospital Los Angeles System The University of Texas Health Madhav Dhodapkar, MBBS, 2017 Angela Koehler, PhD, 2018* Science Center at San Antonio Deepa Sampath, MD, 2018* Yale University Massachusetts Institute of The Ohio State University Iannis Aifantis, PhD, 2016, 2017 Technology Benjamin Ebert, MD, PhD, 2018* New York University School of Ralph Sanderson, PhD, 2017 Dana-Farber Cancer Institute Marina Konopleva, MD, PhD, 2016 Medicine The University of Texas The University of Alabama at Todd Fehniger, MD, PhD, 2017 MD Anderson Cancer Center Birmingham Washington University School of Stefanie Sarantopoulos, MD, PhD, Medicine in St. Louis 2016 Duke University Medical Center

*Newly awarded or renewed grants in Fiscal Year 2018 2017 ACKNOWLEDGEMENTS 5

Guy Sauvageau, MD, PhD, FRCPC, Andrew Zannettino, PhD, 2018* Stephen Oh, MD, PhD, 2018* Screen to Lead 2017 The University of Adelaide Washington University in St. Louis Institut de Recherche en Program Fenghuang Zhan, MD, PhD, 2018* Rebekka Schneider, MD, PhD, 2018* Immunovirologie et en Cancerologie The University of Iowa RWTH Aachen University Adolfo Ferrando, MD, PhD, 2018* Guy Sauvageau, MD, PhD, FRCPC, Columbia University Medical Center 2018* Gary Reuther, PhD, 2018* Institut de Recherche en Translational Research IWMF Grants H. Lee Moffitt Cancer Center & Immunovirologie et en Cancerologie Program: Renewal Research Institute Barbara Savoldo, MD, PhD, 2018* This program is run in partnership The University of North Carolina at John Byrd, MD, 2015 with the International Waldenstrom’s Chapel Hill The Ohio State University Macroglobulinemia Foundation (IWMF). Rising Tide Foundation David Scadden, MD, 2017 Maria Figueroa, MD, 2017 for Clinical Cancer Massachusetts General Hospital University of Miami Shahrzad Jalali, PhD, 2018* Research/LLS Mayo Clinic Lev Silberstein, MD, PhD, 2018* Steven Grant, MD, 2018* Patient-Focused Virginia Commonwealth University Massachusetts General Hospital Larry Kwak, MD, PhD, 2018* Immunotherapy Beckman Research Institute of Daniel Starczynowski, PhD, 2017 Ronald Hoffman, MD, 2017 Initiative Cincinnati Children’s Research Icahn School of Medicine at Mount City of Hope Foundation Sinai Sherie Morrison, PhD, 2018* David Gottlieb, MD, 2017 Ulrich Steidl, MD, PhD, 2017 James Rubenstein, MD, PhD, 2017 David Geffen School of Medicine at The University of Sydney University of California, Los Angeles Albert Einstein College of Medicine University of California, San Ann Leen, PhD, 2017 Francisco Kris Thielemans, MD, PhD, 2016 Bruno Paiva, PhD & Jose Angel Baylor College of Medicine Martinez Climint, MD, 2018* Vrije Universiteit Brussel Dr. James Rubenstein is funded Ronald Levy, MD, 2017 in part by Leon Borchers and Lisa University of Navarra Enrico Tiacci, MD, 2018* Leland Stanford Junior University Scheer & Ed Cone University of Perugia Marzia Varettoni, MD, 2018* Fondazione Italiana Linfomi Onlus Margaret Shipp, MD, 2017 John Timmerman, MD, 2014 Steven Treon, MD, PhD, 2018* Dana-Farber Cancer Institute University of California, Los Angeles Dana-Farber Cancer Institute Dr. John Timmerman is funded in Li Zhang, MSc, MD, PhD, 2018* Special Initiatives part by Luppe and Paula Luppen University Health Network New Idea Award Family Foundation. Ari Melnick, MD, 2015 The following TRP grant funding Weill Cornell Medical College A concept award that funds innova- ended during FY17 and was funded, tive approaches that may funda- Wei Tong, PhD, 2018* in part or full, by a donor. Dr. Ari Melnick is funded in part mentally change the understanding, Children’s Hospital of Philadelphia by the Paul E. Singer Foundation diagnosis and/or treatment of blood Amit Verma, MBBS, 2016 • Dr. Richard Jones was funded Innovation Grant in DLBCL. cancers and related premalignant Albert Einstein College of Medicine in part by The Charles T. Bauer conditions. Charitable Foundation. Markus Muschen, MD, PhD, 2017 David Wald, MD, PhD, 2016 Beckman Research Institute of • Dr. Craig Crews’ funding ended Case Western Reserve University • Dr. Javier Pinilla was funded in City of Hope during FY17 but he was funded in School of Medicine part by Dorothy Fields. Dr. Markus Muschen is funded in part by Dr. Nadia Christensen. Roland Walter, MD, PhD, MS, 2016 part by the Dr. Ralph and Marian Fred Hutchinson Cancer Research • Dr. Roland Walter was fully Falk Medical Research Trust. Center funded by Dr. Dhaval Dhru (included in CDP section) Y. Lynn Wang, MD, PhD, 2017 Transforming CURES The University of Chicago Initiative Dr. Y. Lynn Wang is funded in part by Imagine a Cure for Leukemia. MPN Challenge Grants John Crispino, PhD, 2016 Northwestern University This program is run in partnership George Weiner, MD, 2017 with the MPN Research Foundation. Reuben Kapur, PhD, 2016 The University of Iowa Indiana University – Purdue Amittha Wickrema, MD, PhD, 2017 Angela Fleischman, MD, PhD, 2018* University Indianapolis The University of Chicago University of California, Irvine Phillip Koeffler, MD, 2016 Jianhua Yu, PhD, 2017 James Griffin, MD, 2018* Cedars-Sinai Medical Center The Ohio State University Dana-Farber Cancer Institute Akiko Shimamura, MD, PhD, 2016 Dr. Jianhua Yu is funded in part by Vivian Oehler, MD, 2018* Boston Children’s Hospital Niles Hushka, Jerome Solove, and Fred Hutchinson Cancer Research an anonymous donor. Center

*Newly awarded or renewed grants in Fiscal Year 2018 6 THE LEUKEMIA & LYMPHOMA SOCIETY

Partnerships

Therapy Acceleration Constellation Pharmaceuticals, Inc Kiadis Pharma NV* Cambridge, MA Program Partnerships Amsterdam, Netherlands Giulio Draetta, MD, PhD Kite Pharma, Inc. Acetylon Pharmaceuticals, Inc The University of Texas MD Santa Monica, CA Boston, MA Anderson Cancer Center Ronald Levy, MD Affimed Therapeutics AG Brian Druker, MD The Board of Trustees of the Leland Heidelberg, Germany Oregon Health & Science University Stanford Junior University BioTheryX, Inc. Forty Seven, Inc. OncoPep, Inc. Chappaqua, NY Menlo Park, CA North Andover, MA Ivan Borrello, MD Irene Ghobrial, MD Daniel Pollyea, MD Johns Hopkins University Dana-Farber Cancer Institute University of Colorado Sidney Kimmel Comprehensive ImmunGene, Inc. Stemline Therapeutics, Inc. Cancer Center Camarillo, CA New York, NY Celator Pharmaceuticals, Inc Anand Jillella, MD Princeton, NJ Emory University

Advisors

Medical & Scientific Giulio Draetta, MD, PhD Jonathan Licht, MD C. Casey Cunningham, MD The University of Texas MD University of Florida Santé Ventures Affairs Committee Anderson Cancer Center Alan List, MD William Dalton, MD, PhD Steve Rosen, MD, FACP * Philip Frost, MD, PhD H. Lee Moffitt Cancer Center & M2Gen Beckman Research Institute of former Imclone, Wyeth Research Institute Giulio Draetta, MD, PhD City of Hope Irene Ghobrial, MD Susan O’Brien, MD The University of Texas MD Chair Dana-Farber Cancer Institute University of California, Irvine Anderson Cancer Center Stephen Ansell, MD, PhD Catriona Jamieson, MD, PhD Franklin O. Smith, III, MD* Ross Levine, MD Mayo Clinic, Rochester University of California, San Diego MedPace Memorial Sloan Kettering Cancer Leif Bergsagel, MD Center Larry Kwak, MD, PhD Mayo Clinic, Arizona Beckman Research Institute of Ronald Levy, MD Ravi Bhatia, MD City of Hope Therapy Acceleration The Board of Trustees of the Leland The University of Alabama at Stanford Junior University Michelle LeBeau, PhD Program Advisors Birmingham The University of Chicago Vern Norviel, JD Dana Callow, MBA Renzo Canetta, MD* Wilson Sonsini Goodrich & Rosati Ross Levine, MD Boston Millennia Partners former BMS Memorial Sloan Kettering Cancer Chair Susan M. O’Brien, MD Alan D’Andrea, MD Center The University of California, Irvine Adam Craig, MBBS, PhD Dana-Farber Cancer Institute Medarc Consulting

* Equity investment of $750,000 in Fiscal Year 2017. 2017 ACKNOWLEDGEMENTS 7

2017 National Recognition & Awards Program

We are pleased to recognize Vision for Life Terumo BCT Left Hand Brewing Company the extraordinary involvement of Rocky Mountain Chapter Rocky Mountain Chapter individuals, companies, corporations Award The van Wieringen Family Lehigh Valley Restaurant Group, Inc./ and organizations in their support of Individual, corporation, or organi- Wisconsin Chapter Red Robin LLS and its mission. Those honored zation who, by thinking outside of Eastern Pennsylvania Chapter give of their time, talent and have the box, helped to create a new made a significant difference in San Diego Gas & Electric national campaign or program. the lives of so many. To find out Partners Against Blood San Diego & Hawaii Chapter Rob Braley more about our awards program, Cancer Award Sessions, Fishman, Nathan & Israel, please go to http://www.lls.org/ Mississippi & Louisiana Chapter Ruby (40+ years) LLC national-awards-nomination Gary Jobson Sigma Alpha Epsilon – Georgia Beta Mississippi & Louisiana Chapter Maryland Chapter Georgia Chapter Max Surikov Frank N. Moore, MD, CellCycle Platinum (20+ years) Tri-State Southern Ohio Chapter Congratulations Rocky Mountain Chapter Melissa Abdouch UK Markey Cancer Center Minnesota Chapter to all the 2017 Kentucky & Southern Indiana awardees! Wayzata Central Middle School Chapter Dr. John J. Kenny Minnesota Chapter

Award Wheel & Sprocket Chairman’s Awards Wisconsin Chapter Member of medical community, a Chairman’s Advocacy social worker, or a caregiver who Gold (15+ years) 2017 National supports patient services. 680 The Fan Citation Georgia Chapter Recognition & Matthew J. Matasar, MD Pennsylvania State Representative Long Island Chapter Silver (10+ years) Matt Baker - Chairman, Pennsylvania Awards Cardinal Solutions Group House of Representatives Health Jeffrey V. Matous, MD Tri-State Southern Ohio Chapter Committee Central Pennsylvania Recipients Rocky Mountain Chapter Chapter Hoxworth Blood Center Kim Schuetz Tri-State Southern Ohio Chapter President’s Wisconsin Chapter The Jewish Hospital - Mercy Health Award Marin Xavier, MD Chairman’s Leadership Tri-State Southern Ohio Chapter San Diego & Hawaii Chapter Citation Recognizes a volunteer whose Norton Healthcare personal commitment and Kentucky & Southern Indiana Wayne Berson dedication inspires and motivates Chapter National Capital Area Chapter others to support our mission. Dr. Kenneth B. McCredie Award Runners For Life Tam Driscoll Gary Thompson Texas Gulf Coast Chapter Oregon SW Washington Idaho Individual or corporation who has Montana Chapter South Central Texas Chapter Michael Schuster supported LLS for at least 5 years Tri-State Southern Ohio Chapter James P. Joseph and helped raise more than $1 Long Island Chapter Spiral of Life million. Judge Matt Sebesta Texas Gulf Coast Chapter Tony Lubrano Ray Authement, PhD Award Long Island Chapter Mississippi & Louisiana Chapter The Whitney Foundation Individual who contributes personal Central California Chapter Jason Ryan Imagine A Cure for Leukemia and professional talents to advance Texas Gulf Coast Chapter LLS Canada Bronze (5+ years) an LLS national campaign or Galen College of Nursing Don Ed Wright program. Lynne O’Brien Kentucky & Southern Indiana South Central Texas Chapter National Capital Area Chapter John Kellenyi Chapter (awarded posthumously) PFG/Vistar Generac Power Systems, Inc New Jersey Chapter Rocky Mountain Chapter Wisconsin Chapter 8 THE LEUKEMIA & LYMPHOMA SOCIETY

Special Recognition Rene Michel myTalk 107.1 Karen Grace MVP Video Productions KTMY-FM KENS 5 Eyewitness News Citation Mandeville, Louisiana St. Paul, MN San Antonio, TX Guy Brierre Kevin Mumphrey Sam Nein Sonya D. Heitshusen Mississippi & Louisiana Chapter MVP Video Productions iHeartMedia, Inc. WHO-TV Channel 13 Mandeville, LA Tampa, FL Des Moines, IA Lisa Cooper Greater Bay Area Chapter NARS Andie Summers KDFW - FOX 4 News New York, NY 92.5 XTU Dallas, TX Robert Covay Philadelphia, PA Greater Bay Area Chapter KENS 5 Eyewitness News TheSpy - KOSU-FM KENS-TV Matt Eicheidinger Print Oklahoma City, OK San Antonio, TX Minnesota Chapter Biz New Orleans Alexis Thompson KGW-TV, NewsChannel 8 Chris Flores - League Champion Metairie, LA myTalk 107.1 Portland, OR South Central Texas Chapter KTMY-FM Pam Deller KMBC 9 News Douglas Grimmett St. Paul, MN Lehigh Valley Style KMBC-TV Long Island Chapter Palmer Township, PA Nancy Wilson Kansas City, MO Chris Kegel Cox Media Group Fort Worth Business Press KMOV Channel 4 Wisconsin Chapter K99.1, WHKO-FM Fort Worth, TX KMOV-TV, CBS Dayton, OH John King St. Louis, MO Lehigh Valley Style Kentucky & Southern Indiana 92.5 XTU Palmer Township, PA KPRC 2 Chapter WXTU-FM Houston, TX Pat Selcer Philadelphia, PA The LIUNA Charitable Foundation Lamar Advertising Company KTVT-TV, CBS 11 News National Capital Area Chapter Tulsa, OK Fort Worth, TX Rachel Peniche Television Tyler Media Group John Kukla San Diego & Hawaii Chapter Oklahoma City, OK ABC 8News - WRIC-TV KDFW-TV Bill Rawlings Dallas, TX Lamar Advertising Company Richmond, VA Georgia Chapter Guaynabo, Puerto Rico Barclay Bishop Clay Loney Chris Wilson WJBF NewsChannel 6 FOX23 News Central California Chapter Augusta, GA Tulsa, OK Richard T. Wright Radio Leslie Bohl Larry Michael Western & Central New York Washington Redskins Cox Media Group WOAI-TV Chapter Ashburn, VA K99.1, WHKO-FM News 4 San Antonio Today Casey Zylla Dayton, OH San Antonio, TX Larry Moore Minnesota Chapter KMBC 9 News Anna de Haro Eric Braate Kansas City, MO iHeartMedia, Inc. KPRC 2 Dallas, TX Houston, TX NBC10 Philadelphia WCAU-TV 2017 Media Josh Delozier Drew Carney Bala Cynwyd, PA TheSpy - KOSU-FM KGW-TV, NewsChannel 8 Awards Oklahoma City, OK Portland, OR Kerri O’Brien ABC 8News - WRIC-TV Recipients iHeartMedia, Inc. CBS6 - WTVR-TV Richmond, VA Dallas, TX Richmond, VA Recipients have a record of Joe Silvestri iHeartMedia, Inc. Doug Dunbar excellence in promotional support Good Day Street Talk Tampa, FL KTVT-TV, CBS 11 News & fundraising, as well as educating Fort Worth, TX Fox 5 NY and informing the public of the LLS iHeartMedia, Inc. New York, NY 100.3 FM - WHTZ Fire on the Bayou organization and its mission. Tina Stoklosa New York, NY New Orleans, LA NBC10 Philadelphia Skeery Jones FOX23 News - KOKI-TV Bala Cynwyd, PA Digital Z100 Elvis Duran & the Morning Tulsa, OK Eileen Whelan Show Laura French CARAT WJLA NewsChannel 8, ABC7 CBS6 - WTVR-TV New York, NY iHeartMedia, Inc. Arlington, VA New York, NY Richmond, VA Jim McKinnis WHO-TV Channel 13 Good Day Street Talk The Integer Group KRMG Des Moines, IA Fox 5 NY Dallas, TX Tulsa, OK New York, NY 2017 ACKNOWLEDGEMENTS 9

WJBF NewsChannel 6 Philanthropy Award Patti Robinson Augusta, GA The Volunteer Kaufmann Spirit Award WJLA NewsChannel 8, ABC7 Leadership Individual, family, or foundation that Arlington, VA demonstrates outstanding philan- An incredible patient access volun- Conference thropic leadership in support of LLS teer and survivor. WLKY Channel 32 Mission. Louisville, KY 2017 Elite Award Theresa Stevens Michael Copley San Diego/Hawaii Chapter WOAI-TV - News 4 San Antonio Recipients Chairman, LLS’s Beat AML Today Campaign San Antonio, Texas Recognize outstanding contributions John Kellenyi Robert de Villiers and achievements of a select group WRGB Channel 6 News Vice Chairman of LLS’s Beat AML of LLS volunteers and organizations Award Schenectady, NY Campaign making an extraordinary impact for LLS and its mission. The highest honor and pinnacle of achievement for a volunteer, named Other Volunteer Leadership after the son of LLS’s founders. Mark Romig National Corporate Award Dave Frantze New Orleans Tourism & Marketing Mid America Chapter Leadership Award Recognizes a volunteer with exem- Corporation plary leadership and extraordinary New Orleans, LA Corporation/organization with dedication to LLS and its mission. Sidney D. Torres, IV fundamental alignment to the LLS Brad Vick IV Capital mission. Minnesota Chapter New Orleans, LA United Food and Commercial Workers Pinnacle Award

The Excellence in Individual who has demonstrated Policy Advocacy exceptional leadership, dedication, Award and extraordinary commitment to LLS campaign fundraising efforts Volunteers who have successfully and the overall LLS mission. advocated for policy changes that John Greene will have a real impact on blood Greater Bay Area Chapter cancer patients. Kathy Hawkins Central Pennsylvania Chapter 10 THE LEUKEMIA & LYMPHOMA SOCIETY

Donors

We gratefully acknowledge the $500,000 - $999,999 Floyd Singleton KPMG individuals, foundations and corpo- Stater Bros. Charities Lehigh Valley Restaurant Group, Inc./ rations that generously supported PA R C Amgen, Inc. Truist Red Robin LLS’s mission during this fiscal year. Barclays Wells Fargo Joyce and Larry Lacerte* BMC Western Digital Katherine and James Lau* Elbit Systems of America LG Peeps Pharmaceutical Funding Lang/Stiglitz Family Fund Lieblich Family Gift Fund* Legend $100,000-$249,000 Kathryn and Rush Limbaugh Tisha Lindberg PA Patient Access PA C Pfizer, Inc. 7 Eleven Alon The Lyon Family Foundation PP Public Policy PVH ADF Companies - Pizza Hut Bonnie Magid Roditti* R Research Sarah Cannon Blood Cancer Aetna The Marge & Charles Schott C Campaign Network James Allen Foundation* Subaru of America, Inc. Alto-Shaam, Inc. Clyde S. McGregor and LeAnn Teva Pharmaceuticals PA Pedersen Pope * Denotes multi-year commitment Ameren Missouri Medtronic Foundation The Wawa Foundation Anthem Blue Cross Blue Shield Merck & Company PA Astellas R Muy! DBA Wendy’s $1,000,000 and Above $250,000 - $499,999 At Home NARS BD PA PP R C AbbVie Inc. Advisors Excel Team NewYork-Presbyterian Blue Cross and Blue Shield Monica and Timothy Babich* BDO USA, LLP NSC Global Ltd.* The Boldt Family Philanthropy Fund* Dr. Evelyn Bata Bloomberg Lynne and Gregory O’Brien Janice and Peter Brock* PA R C Bristol-Myers Squibb Carolinas Healthcare Foundation* PhRMA S. Lori Brown Burlington Carter’s, Inc. PwC Barry Cheskin and Lisa Norcia* PA R PP C Celgene Corporation Circle of Service Foundation* Rahr Corporation* The Coleman Foundation, Inc.* Cynthia and Frank Gasztonyi* Dhaval Dhru Maria Ramos-Person Liz and Michael Copley* PA PP C Genentech/Biogen Discount Tire The Reinalt-Thomas Corporation Dell - Silicon Valley Community PA C Gilead Sciences, Inc. The Dougherty Family Foundation Foundation Silicon Valley Bank The Harry T. Mangurian, Jr. Marian Dozier* Deloitte Southwest Convenience Stores Foundation* Dr. Ralph & Marian Falk Medical Ann and John Doerr Terumo BCT LIUNA Charitable Foundation* Research Trust Earl D. and Marian N. Olson Fund Textron Matching Gift Program The Norcross Foundation, Inc. In Charles Esten* EY Angela and Gary Trovato* Memory of Herrick F. Norcross, Jr. FIS UCLA Health (Rick)* F. M. Kirby Foundation, Inc. Global Franchise Group Walt Disney Company Foundation The Olive Garden Italian Restaurant Florida Cancer Specialists Goldman Sachs Weill Cornell Medicine PA PP C Andrew Foley Pharmacyclics/Janssen The Herman O West Foundation Randolph Writz Donald Porteous* Fox5 WTTG IHOP Anonymous (2) Salesforce Furniture Fair PA Incyte Corporation The Sarah Cannon Fund at the HCA Chiyoko Furukawa* John B. Kellenyi (Late) Foundation* GE Foundation $50,000-$99,999 PA PP Kite Pharma PA PP C Takeda Oncology GEICO Christine and Timothy Lindenfelser* 14 Foods / Dairy Queen The United Food and Commercial HM Insurance Group Nike ABM Onsite Services, Inc. Workers International Union (UFCW) Kristin and John Hyland Novartis Pharmaceuticals PA PP Agios Pharmaceuticals, Inc. PA PP The United Food and Commercial The Jake Wetchler Foundation Workers International Union Canada/ Orokawa Foundation All Round Foods Bakery Imagine a Cure for Leukemia TUAC Perfumania Products, Inc. PA Jazz Pharmaceuticals, Inc. Walgreens Renaissance Charitable Allegheny Foundation Juno Therapeutics, Inc. PA Foundation, Inc. American Airlines Karyopharm Therapeutics, Inc. PA Rising Tide Anthemic, LLC 2017 ACKNOWLEDGEMENTS 11

The Arthur M. Blank Family McKesson Specialty Health Alex and Ani Comier Foundation Medical Mutual The Alice Lawrence Foundation, Inc. Community Foundation of New AstraZeneca Pharmaceuticals PA R Mercer Patrick Allender Jersey Bank of America/Merrill Lynch Thomas Moore Allstate Insurance Company Community Foundation Sonoma County Anthony Becht Moppie’s Love Alverin M. Cornell Foundation Currie Garner Family Fund The John and Frances Beck Family Kevin Morris American Systems Foundation Daiichi Sankyo PA Tommy Morrison Madeline and Stephen Anbinder C. Kenneth & Laura Baxter Dana-Farber Cancer Institute Northrop Grumman Jean and C.E. Andrews Foundation, Inc. David F. Weeda Foundation Northwestern Mutual - Minneapolis Angel Wings Foundation The Blackstone Charitable David M. Polen Retirement Plan Trust Foundation NYCB James Bailey and Roann Costin Dealer Tire C.J. Coakley Inc. Pacific Union Bank of America Del-Camp Investments Inc. Cancer Treatment Centers of Pamela B. Katten Memorial Barreto Family Deltek, Inc. America Leukemia Research Foundation Kaspar Basse Digitas Health Philadelphia CareFirst BlueCross BlueShield Ping Y. Tai Foundation, Inc. Baylor Scott & White Edith M. Schweckendieck Trusts Ron Cohn Postage Stamp Farm Foundation BB&T Edward B. Dunlap, Jr Foundation Comcast PRG Benchmark Rehabilitation The Edward G. & Kathryn E. Mader Communities Foundation of Texas Rampart High School Bert Smith & Co. Certified Public Foundation Community Visionary Enterprises Amber and Tim Randolph Accountants EFESTĒ David Yurman Suhail and PJ Rizvi Beta Engineering Equestrian Sport Productions, LLC William Dickinson Robert E. Gallagher Charitable Trust Black Dog Charity Everyday Health, Inc. DLA Piper, LLP Janet and Martin Robertson Susan and Ed Blumenfeld Ezralow Family Trust Dominion Nancy and Richard Rogers Bob Ruth Ford, Inc. FarmHouse Fraternity- Troy Scott Safety Bon Secours St Francis Cancer Enmark Stations, Inc. University David Salmanowitz Center First NBC Fernandez Foundation, Inc. Melvin and Valorie Booth Sanofi-Aventis U.S., LLC PA Flamingo, Inc. First Weber Group Foundation Sarver Charitable Trust Leon and Michael Borchers* Ethel and Bernard Garil Florida Power & Light Company Linda Schwartzstein* Bowlman T. Bowles Generac Power Systems For Julie Foundation, Inc. Stephen A. Schwarzman Brayton Purcell, LLP Gexa Energy Forward Advantage Foundation, Inc. Lauree and Robert Simmons Breeden-Adams Foundation Neda Ghahremani The Foundation at Rolling Hills Mary Elizabeth and George Smith Todd Brinkmeyer Guggenheim Life and Annuity Chad Frampton Southwestern Ohio Wendy’s Pamela and Morris Brown Hargrove Franklin American Mortgage BTIG, LLC Hildegarde D. Becher Foundation Starfish Foundation Company Jeff Burch Inc. Todd Reed McClintock Research Garden City Turkey Trot Race Infor Global Solutions Foundation C.H. Robinson Worldwide Committee, Inc. The J. Willard & Alice S. Marriott Sidney Torres, IV Capital One General Dynamics Information Foundation Trevor Loughlin Foundation Inc. Michael Capone Technology Hamilton E. James UC Irvine Health Care Carlos Batista Foundation Patricia and Chris Giannoulias Jerome S. & Grace H. Murray UPMC Carlson Family Foundation, Inc. Giant Food Foundation Kathryn and Leo Vecellio Carz Cruizn, INC. Greehey Family Foundation Jersey Mike’s Subs The Victor E. and Caroline E. Casino Arizona Rachel and Eric Green Johnson & Johnson Schutte Foundation - Trust E CB Richard Ellis-N.E. Partners, LP Hackensack University Medical Gerald Kafka & Rita Cavanagh Walmart Kim and Sammy Cemo Center Richard Kay Angie and Don Ward Centene Corporation Jen Hall Kent’s Run Washington Area Mercedes-Benz The Chambers Family Foundation The Handlery Foundation Dealers/Mercedes-Benz USA, LLC Emily and Neil Kishter The Charles T Bauer Charitable Hannig Law Kolache Factory The Wellmark Foundation Foundation Pete Harman Koppers Chesmar Homes CT, LTD. The Harry and Jeanette Weinberg Paul Leinwand $25,000-$49,999 Circle City Foundation Foundation, Inc. Lighthouse Investment Partners, LLC Cleveland Clinic Hazmat/Kenworth 27th Group Louisville Metro Government Cohn Family Foundation Heartland Blood Centers Accredited Home Lenders Donna Lyon CohnReznick Higgins Family Charitable Foundation Fund Foundation Mallinckrodt Pharmaceuticals The Colton Company Akin Gump Strauss Hauer & Feld, Highland Park Village LLP 12 THE LEUKEMIA & LYMPHOMA SOCIETY

Highmark Massapequa Turkey Trot, Inc Schafer Family Foundation $10,000-$24,999 Al Hill Jr. MAXIMUS Foundation Helena Scott David Hitz Mazda North American Operations Seedlings Foundation Abacus Technical Services, LLC Howard Family Foundation McKesson Specialty Care Solutions Sempra Energy Foundation ABC 7/WJLA-TV Huntsman, LLC Medical Properties Trust Sentrillion, LLC Daniel and Megan Abeln Niles Hushka MedImmune Shlomo and Tamar Rechnitz Charity Acadia Realty Limited Partnership Hy-Vee, Inc. Melryder Foundation* Foundation Accel PA ICAP Services North America, LLC Merck Foundation Shire Accenture iHeartRadio Mobile Beacon Sidley Austin, LLP Access Point, Inc. In Loving Memory of Betty Karpinski Janice Moran Solutionreach, Inc. Accord Healthcare, Inc. J Frank Schmidt Family Charitable Morgan, Lewis & Bockius, LLP St. Joseph’s/Candler Hospital Accountable Health Solutions Foundation Jack Morkan and Clare Vanderbeek Donald Steiner Accura Calibration J.T. Tai & Co. Foundation, Inc. Beverly and Stephen Movius The Stephen Birnbaum Foundation The ACE Family Foundation Scott Jackson Mud Pie Stormont - Vail, Inc. Ann Milton Adams Jersey Mike’s Corporate Advertising MUFG Union Bank Trust Dept Michael Sweig Advantage Pharmaceuticals Fund North Bay Cancer Alliance Sylvan/Laureate Foundation AEG Global Partnerships Jessica Drew Sunshine Memorial Northside Hospital Texas Capital Bank Agency Rx, LLC Fund PA Notre Dame Academy High School, Texas Oncology Isao Aiba The Jim Jacobs Charitable Inc. Thunderbirds Charities Air Products Foundation Foundation Jerome Oakey and Laura Randolph Tigerfight Evelyn Akers John Theurer Cancer Center Odin, Feldman & Pittleman, PC Baker Tilly Alamo Group Cynthia & Dan Johnson Otsuka America Pharmaceutical, Inc. Toys R Us Children’s Fund Albany Rods and Kustoms, Inc. Kaiser Permanente Financial SVCS Albertsons Safeway OPS PenFed Treen Events Albrecht Family Foundation The Kakaty Family Penn Medicine UF Cancer Center at Orlando Health Alliance Construction Group Susan and Daniel G. Kane Peoples Natural Gas UNC REX Healthcare Alliance Data Tammy Karnes Stephanie and Scott Petty United Way of Greater Milwaukee Alliant Insurance Services, Inc. Keller Williams Realty McLean PFG/Vistar UPS Allison-Smith Company Kent Island American Legion Philadelphia Multiple Myeloma Valero Energy Foundation Networking Group Allmond & Company, LLC The Keri Shull Team Vanda Pharmaceuticals Inc. Plaid Pantries, Inc. Allstate Foundation David Kopp Venable, LLP Planned Systems International The Altschul Foundation Kosair Charities Committee, Inc. Phil Venables Plastics Industry Association AM Charity Fund Kroger Co. Foundation Virginia Sheldon Jerome Foundation Poker Central, LLC Amegy Bank The Kroll Family Foundation Michael Vlock PricewaterhouseCoopers American Construction Company Don C. and Diane S. Lake Family VyStar Credit Union Publicis Health Media American Direct Marketing Legacy Mutual Mortgage W.R. & Norma Ramsey Foundation QuintilesIMS Resources LLC Eugene Lewaniak Waddell & Reed/ Ivy Investments The Randy and Barbara Ann Frankel American Electric Power Lilly USA, LLC Washington Business Journal Foundation American Insurance Group Lindy Paving Washingtonian J. Miles Reidy AmerisourceBergen Foundation Lockton Companies, LLC Ellen Weissberg Riemer & Braunstein, LLP The Tarang and Hirni Amin Family Louisville Jefferson County Metro Gloria Weissberg Robbins Family Foundation Fund Government M. Weissberg The ROMA Foundation AmTrust Bank/NYCB Amanda and Jody Lucero West Endowment Ronald Caporale Anadarko Lunardi’s Market West New York Restoration of CT, Debra Ross Denise Andriello-Higgins Luppe & Paula Luppen Family Inc. Anne Arundel Health System Foundation RSM US Foundation Wet Willie’s Management Corp. AppLovin M&T Bank & Wilmington Trust Joan and Paul Rubschlager The William J. Shaw Family Arcadia Realty Limited Part. Macquarie Group Runners for Life Foundation AREVO Group, Inc. West Marine Runners for Life Houston, LLC William R. Rich Foundation Argen The Mark Becher Family Giving The Ryan Foundation Brenda and James Wishbow Fund Pat and Jeff Sachs* Donna and Glen Wolther ARIAD Pharmaceuticals, Inc. Paula and Larry Marshall SAIC WTOP Radio Matthew Arno Mason City School District San Jose Earthquakes Anonymous (4) Array Marketing Arlene Schafer 2017 ACKNOWLEDGEMENTS 13

Arrow Exterminators Berkshire Bank The Callow Family Commerce Bank Robert Ashby The Bernal T. Chomeau Private Mark Campana Commonwealth Land Title Insurance Ashwood Constructions, Inc. Foundation Renzo Canetta Company ASRC Federal Holding Company, Bessemer Trust, Jeong Kim John Cao Community Medical Centers LLC BIO Capgemini US, LLC Robyn and Don Conlon The Associated Credit Union BioClinica Capital City Bass Masters Agnes Connors Foundation Stanley Birkhead Capitol Federal Foundation Conti Family Foundation Assurant Stacey and Seth Blackman TJ Caplinger Continental Food Management Assurant Specialty Property (Wendy’s) Thomas Blair Carahsoft Technology Corporation Astex Pharmaceuticals John Convery Christine and Leroy Blanchette Carl and Henrietta Herrmann Family AT&T BLG Trust Foundation Katherine Cook PA Atara Biotherapeutics, Inc. Blues for Kids Foundation Carlton Family Foundation The Phyllis M. Coors Foundation Athletico Management, LLC BMO Harris Bank Carnival Foundation Cora and John H. Davis Foundation Atlanta Fine Homes Sotheby’s BNY Mellon Corporation’s Carol A. Stuhr Family Foundation Cordia Partners International Realty Community Partnership Colm L. Carr Alison and Mike Corkery David Atlas Traci Bolte Carr Companies Costco Wholesale Augusta Oncology Tammy Bond Linda and Donald Carter County of San Diego - District 4 Daren Austin Booz Allen Hamilton Carter Family in loving memory of Courtney Knight Gaines Foundation The Austin E. Knowlton Foundation Boscovs Jason Crane Composites Austin Hardware & Supply Boston’s Best Coffee Roaster Debbie and Michael Casey Credit Suisse AvalonBay Communities, Inc. John Boyle CBIZ MHM, LLC Ralph Cross Avella Specialty Pharmacy Brady Ware & Company CDI Corporation Cross Country Consulting Steven Averbuch Brandt Companies, LLC Centerpoint Energy Cruise Industry Charitable Babcock Ranch Foundation, Inc. Brandywine Reality Trust Century Elevator Maintenance Co. Foundation Bad Daddy’s Burger Bar Brenda Cheney’s Sip N’ Sail Cerner Corporation CSI Leasing Isabel Bader Brian Chittenden, Legacy Bank Chad’s Lightup Leukemia CSRA Dylan Baker Bright Funds Foundation Christina and Lawrence Chapman Curis, Inc. Jack Baker BriteVerify Charlotte Radiology Cushman & Wakefield Baker Botts Broadstreet Pancakes, Inc. DBA Chase CW Capital Baker Concrete Construction IHOP Chef’s Market Cafe & Takeaway D.A. Davidson Companies Baker Hughes Foundation Andrew Brock Chiaramonte Construction Company D3 LLC Gold Sponsorship Baker Roofing Company Michael Brooks & Maria Fotiu Children’s Mercy Hospital - Kansas Danielle D’Aiello BankSouth Brown Gould Kiely City Danaher Corporation Banner MD Anderson Cynthia and Joe Bruno Chipotle Daniel & Karen Lee Family The Bar LV William Bryan Christus Health Santa Rosa Foundation The Bar Method Jane Buckley Chucky’s Champions, Inc. Darrenkamps Mount Joy Market, Inc. The Barbara and William Rosenthal Buckley Family Charitable Church & Dwight Employee Giving David Spence’s Cancer Fund Family Foundation Foundation Fund Donald W. Davis Nonnie and John Barbey Mike Budenholzer Cincinnati USA Regional Chamber Elaine and Jim Day Barings Bullock’s Cruise In Citco Canada Glen de Vries John Barr Sandy Burden Robert Citrone The DeBruce Foundation Bartlett Cocke General Contractors Michael and Sarah Burke Cynthia and Christian Clark Deerpoint Group, Inc. Michael Bartschat Business Review Journal Susan and Jay Clark David & Barbara Dehaemers Lee Bates Jennifer and Jeffrey Butler Clark Construction Group, LLC Jason Dehaemers Bath Fitter Butler Family Foundation Harland Clarke Dekker/Perich/Sabatini, Ltd Douglas Baughman By Light Clarkson Eyecare, Inc. Delta Dental BCH Events Dr. John Byrd Clearview Cancer Institute Demolition and Environmental Beacon Capital Partners C. Jay Moorhead Foundation - Huntsville Company, LLC Beardmore Subaru Mary Cahill Clune Construction Company Denver Beer Olympics Beltway Cleaning Services Caliber Collision Coca-Cola Denver Region Toyota Dealers Association The Belvedere Cove Foundation California Coast Credit Union Cocherl Family Foundation DEPCOM Power Bender Foundation, Inc. Callaway Golf Company Patrick Colligan Christine Comaford Robert Dickinson 14 THE LEUKEMIA & LYMPHOMA SOCIETY

Joseph Dimenna Marc Ezralow Foundation The Helis Foundation Dittmar Company Fairmont San Jose George and Mary Josephine Henkels & McCoy Inc. The Division of Hematologic FALL Golf Classic Hamman Foundation Henry Schein Cares Malignancies and Cellular The Fama Family Charitable Fund The George F. & Myra Shaskan Hewlett Packard Enterprise Therapeutics Foundation, Inc. Fansler Foundation Donnie & Marcie Hill DLE Equipment George L. Shields Foundation, Inc. Faramarz Fardshisheh Hilltop Center, LLC DoMyOwnPestControl.com The Gerald and Paula McNichols Federal Realty Investment Trust Sam Hirbod Lucy and Bob Donahue Family Foundation Edward Fein HITT Contracting, Inc. William J. Dore Gila River Casinos Gail Fernandez The Hitz Foundation Paul Dorman Ann and Peter Gilbert America Ferrera HM Life Insurance Company Mary Jo Dougherty and Mike Roark Global Payments, Inc. The Ferriday Fund Charitable Trust Hogan Lovells US, LLP Doylestown Health Cancer Institute Global Traveler Fidelity Brokerage Services, LLC Holistic Financial Partners Driscoll’s David Gochman Dorothy Fields Hope 4 Adam Max Duckworth Jason Goldberg Findlay Automotive Group Liz Hoster Duke Cancer Institute Goldberg Charitable Trust Constance Fischer Hot Ticket Racing Milane Duncan-Frantz Lee Goodwin and Linda James Fisher Schwartzstein Houston Methodist The Woodlands Dyer Family Foundation Hospital Annie Flaig Tammy Gorham E. & J. Gallo Winery Howard Burris Family Gift Fund Flamingo Charities, Inc. Bob Graham E E Reed Construction, LP Howard Hannah Real Estate Florida Crystals Corporation Grant Thornton LLP The E. Kenneth And Esther Marie Services FMC Corporation Greenberg Traurig Hatton Foundation Eric Hoxsie Ford UAW Parts Depots Grip It & Rip It e3 Wealth The Hughes Family Fox Valley Hematology & Oncology Bosa Grubich Eastdil Secured, LLC Richard Huxtable Fragrance Resources Anthony Guadagnino Deane Eastwood IBERIABANK Dianne and Richard Franco Janet and David Gualdoni Eckert Seamans Cherin & Mellott ICE Mobility Commie Frankino Gulf Coast Bank & Trust Co. ECN Financial LLC ImmunoGen Frauenshun Hospitality Group of Ed & H Pillsbury Foundation Jeff Gusinow TN, LLC Independent Health H. Lee Moffitt Cancer Center & Ed Morse Automotive Group Indepth Gives Back Fred Smith Plumbing & Heating Co. Research Institute The Edgerley Family Foundation Infinity Pharmaceuticals Freeman Boatworks, LLC HAC, Inc. Gerald Eisenberg InfraSource, LLC Freepoint Commodities, LLC Hadden Landscape, Inc. Trisha and Chuck Elcan Insulators International Health Freight & Salvage Coffeehouse The Laverna Hahn Charitable Trust Element Financial Corporation Hazard Fund Friedman Advisors, LLC The Hallem Family Emerson Charitable Trust Intouch Solutions Friends of Katelyn Corb Hankey Enerplus IPA Foundation Frank Furia HARD Summer / Live Nation, Inc. The Enrichment Foundation Iroquois Middle School G3 Enterprises Harkin Builders, Inc. Enterprise The Irwin and Ginny Edlavitch Gables Residential Harlan Community High School Enterprise Holdings Foundation Galen College of Nursing Janet and John Harper Enterprise Rent-A-Car The Isaacson IRV Trust Garber Automotive Group Daniel Harrington Epizyme ISN Carlos Garcia Charles Harthan ePlus Technology, inc. Ivie & Associates Israel Garcia Clyde V. Hartline Jr. EQT J.P. Morgan Gardner Family Trust Donna Hartman Eric Scherbarth Leukemia Research Jack Henry & Associates T.H. Garner Foundation The Harvey E. Najim Family Jack Link’s Gary and Pennie Abramson Foundation The Escher Foundation Jane and David Jackson Charitable Foundation Harv’s Car Wash ESPN908 Jackson EMC The Gaughen Management Group Allen Hawkins Amir Etezazi Luke Jaindl Chris Gautreau HCA West Florida Evolution Fighting Championship Jaindl Beverage Co Gaylord Hotels Healthcare IT Leaders LLC Jaindl Farms, LLC Frank Geary Heartland Express Inc. Expeditors The James Cancer Hospital & Anonymous Express Scripts, Inc. Heathcare Management Solove Research Institute Gene Foundation Administrators Eye Center of Charleston The James H. Reid, Jr. Family Genpact HEB Grocery Company Bryan Ezralow James River Equipment The George & Lena Valente Heidrick & Struggles, Inc. James T Ueltschi Foundation 2017 ACKNOWLEDGEMENTS 15

Jan3150J LLC Joseph Kopser Allison and Howard Lutnick Megan’s Wings, Inc. Jacqueline Jankowski Geraldine and Charles F. Kriser M7 Aerospace Danielle Meier Janus Henderson Foundation Lisa and Steven Kristel Mabee/Gumpert Philanthropic Fund Joseph Meisner Brian Jaramillo Shannon Krogh Mack Madness, Inc. Otilia Melwani The JBG Companies K-VAC Environmental Services, Inc. Robert Maher Members 1st F.C.U. JE Dunn Construction Luz Kyncl Major Hyundai Memorial Health University Medical Jewish Federation of Cleveland David Labuda Make Yourself Foundation Center John Edward Fowler Memorial Stacy Lachapelle Chuck Malk Merchandise Pickup Service, Inc. Foundation Ladish Co. Foundation Manatt, Phelps & Phillips, LLP Meritor, Inc. The John G. Rangos, Sr. Charitable Eddie Lafferty Manpower International, Inc. Caren and Phillip Merrick Foundation The Laffey McHugh Foundation Maple Grove Elementary School Cayre and Alexis Michas The John Newell Wade Foundation Lake Family Foundation Mariner Holdings, LLC Microsemi Corporation John Wall Family Foundation Lake Norman Chrysler Dodge Jeep Mark Miller Toyota Miles & Stockbridge, PC Diana and Murray Johnson Ram Lois Markovich Mark Milla Judith and Jack Johnson Lalezarian Properties The Marksmen Company Miller Paint Company Louise Johnson PA Kelley and Jay Lamy Marquise Auction Eric Miller, MD Edward Jones Land Rover Marsh Risk & Insurance Services Nancy and Patrick Minan Jones Day Landmark Construction John Marten Rusty and Barry Minkoff Jones Lang LaSalle Tracy and Ben Lange Lucy Martin Mitsubishi Hitachi Power Systems Karen and Kent Jordan Langford Electric, Inc. Martin-O’Neil Cancer Center Mizuho Americas George Joseph Lisa Lawin Marty’s, Inc. Monta Vista High School Aaron Joyce Allison Lee Marylou’s Coffee Frank Moore June & Cecil McDole Charitable Left Hand Brewing Company Mashkin Family Foundation Donald Moreau Fund Leo Seal Family Foundation Massachusetts General Hospital Morgan Franklin Consulting, LLC K Machine Industrial Services Leon S. Peters Foundation Kim and Matt Mausser Morgan Stanley Kaiser Permanente Ted Leonsis Maverick Capital Foundation Morgan Stanley Foundation The Kakaty Family Lewis Wagner, LLP Jon Maxson Sasha Moritz Kansas Ready Mix, LLC Jason Leyva Frederic Mayerson Morris & Templeton Insurance Kappa Sigma Theta-Delta Life Science Tech, LLC Mayo Clinic Cancer Center Marcie Morrison Kathryn Dent and John L. Tillman LifePoint Health Mayo Foundation for Medical Traci and Bill Morrow Charitable Fund Lightning Foundation, Inc. Education and Research Brint Morrow Kayleen Larson Legacy Foundation Linn Ligon Mayo Performing Arts Center Alicia Moya KBS Trucking Lillie Young & Associates, LLC MB Financial Bank Elizabeth M. Mungo KCE Structural Engineers Mike Linares Thomas McCarthy John Murphy Mary Beth and Christopher Kearns Connie Lindsey McCownGordon Construction Murray & Guari Trial Attorneys Thomas Kelley* Lion Apperal Alta and Henry McCrary Names Family Foundation Keiser James Lites Laura and Paul McDaniel Leslie and Larry Nance Keith Busse Enterprises Live Nation Worldwide, Inc. - TSO McDermott Will & Emery NASCAR Foundation Kennedy Lane, LLC Lizanell and Colbert Coldwell Erin and Sean McGould National Philanthropic Trust Diane and Bill Kenny Foundation The MCJ Amelior Foundation National Rural Utilities Cooperative KentuckyOne Health Locke Lord, LLP Kathy and John McKinley Finance Corporation KeyBanc Capital Markets Lockton Companies Stephanie and Edward McLaughlin Nationwide Vision Center PC KeyBank National Association David Longo Matthew McManus Nature Nate’s -The Honey Rock Kiddar Group Holdings, Inc. Fund Loretto Kane, John and Rosanne Scott McManus Kilroy Realty, LP Strittmatter Nature’s Variety Michele and Scott McMullin The Kirlin Group Lori & Rick Rosmann Foundation John Nauseef Jennifer and Robert McNeil Stuart Kirscht The Lotz Family Foundation Nebraska Medicine William McNitt John Kisthardt Low Book Sales Nestle Purina PetCare Company MD Anderson Cancer Center Chuck Kiven The Lowlands Group, LLC NetApp Mead Land Services KLA Laboratories, Inc. Bruce Lowthers The Netter Foundation Medidata Chris Kolb The Ludwig Family Foundation, Inc. New Car Dealers Association Meg and Bennett Goodman Family Koons Arlington Toyota Lustine Toyota Dodge Foundation Newmark Grubb Knight Frank 16 THE LEUKEMIA & LYMPHOMA SOCIETY

The Newsletter Pro Penn Station East Coast Subs Thomas Raffa Karen and Ernie Rosenberg NextEra Energy, Inc. Penn Waste, Inc. Rambus Lee Rosenthal The Niello Company Pennant Foods Corp DBA Wendy’s The Randy and Deborah Daniel Roslyn Savings Bank Nimble Storage Timothy Penney Family Charitable Foundation Ross Auerbach NOCO PEP Promotions Barbara Rapaport Royals Charities, Inc. Guy Nohra Pepco Holdings, Inc. Raymond James Financial RPM Pizza (Dominos Pizza) Georgia North Pepsi RCCA MSO, LLC Run This Town 5K North American Development Group Performance Honda Automotive Real Estate One Foundation Ruoff Home Mortgage Northwell Health Network RED Capital Group Chris Russell The Northwest Company, LLC Whitney and Scott Perkins Reece Holbrook Win Anyway The Rutter Foundation Foundation, Inc. Northwestern Mutual Foundation Ernest Pestana Ruttura & Sons Construction Lisa and Bob Reeves (WI) Pete Pugh Family Fund Jeffrey Sachs Mark Regante Norton Cancer Institute Donita and Sheldon Petersen The Safeway Foundation Regeneron Pharmaceuticals, Inc Norton Rose Fulbright US, LLP PEW Charitable Trust Saint Benedict of New Jersey Reily Foods Company Nova Restoration PGA TOUR Superstore Lauren and John Salata Angela and Michael Remen NPL Construction Company The Phase Foundation Harvey and Yetta Saltzman David Rendina NWN Corporation The Philadelphia Foundation Sam I Am Foundation Marjorie Rendina Morgan O’Brien Tom Philbrick Sam J. Frankino Foundation Tricia and Richard Rendina OHC Philly Open for LLS Sam Swope Family Foundation, Inc. Rendina Healthcare Real Estate Richard Ojeda Phoenix Suns Charities, Inc. Samuel C. Cantor Charitable Trust James Resnick Olafson Foundation Pi Kappa Alpha Fraternity Samuel P. Mandell Foundation Resolution Run to Kick Cancer, Inc. Chad O’Leary Melissa and Mark Pietramale San Diego Sign Company Chad Reynolds The Omer Foundation Pietro’s Restaurant Group Sanofi Genzyme The Rhoda and David Chase Family Wendy and Mike O’Neil James R. Pignataro SAPNS2 Foundation, Inc. Nita and Michael Onustock Pilot Travel Centers, LLC John Saunders Richard & Terez Abatecola Ostroff Associates Pineapple Classic Foundation Foundation Rick Schaden Oxford Development Pitt Ohio The Richard and Charlotte Orear Schantz Orchards, LLC Pacific Coast Companies, Inc. PMG – Property Markets Group Charitable Foundation Lisa Scheer and Ed Cone Pacific Service Credit Union PNC Bank Richard M. Schulze Family Scheid Family Wines Mr. and Mrs. James F. Palmer PNC Financial Services Group Foundation Jeff Schoepfel Palo Alto Networks Foundation PNC Real Estate Nina Richardson Schorr-Lieberman Family PAR Electrical Contractors, Inc. Polen Capital Rick Hendrick Chevrolet Foundation Lynne Parshall Polo Ralph Lauren Foundation Ride Event Marilynn and William Scully Joan Parsons Ports America Linda and Paul Ried Seaboard Corporation Mary Parsons The Power Of Bowser Rifenburg Construction Seacap PathGroup PPG Industries Riot Games Seattle Cancer Care Alliance

PA Patrick & Linda Foy Family Monika and John Preston RNDC South Carolina, LLC Seattle Genetics Foundation Priority Physicians RoadID Mark Seltzer Patrick A. Bianchi Revocable Trust Private Advisor Group The Robert and Tia Gierkink Sempra Employee Giving Network Larry Patterson ProCon, Inc. Philanthropy Fund Sessions, Nathan, Fishman & Israel Paul and Sandy Edgerley Trust Fund, PSEG Foundation Robert I. Goldman Foundation Shelley Shackelford Fidelity Public Service Enterprise Group The Robert Sprague Foundation The Earl and Brenda Shapiro The Paul and Sharon Dillon Family Incorporated Ruth Robinson Foundation Fund The Pumping Station, Inc. Rock Spring Contracting, LLC Dave and Sally Shepherd The Paul B. Greetin and Beryl S. QIBQ, Inc. Rockefeller Group Sherwood Forest, SC Greetin Foundation, Inc. Quality King Distributors Roderick S, Flossie R, & Helen M Shutterfly The Paul E. Singer Foundation Quest Diagnostics Galloway Foundation, Inc. Linda and Bart Sichel Gina and Michael Pavelec Kathleen and Edward Quinn Lynn and Peter Rogers The Sidney, Milton and Leoma Pegasus Builders, Inc. Mona and Peter Quinn Thomas Rogers Simon Foundation Anthony Pellegrino LaRae and Roger Quy The Rogers Family Foundation Signature Premier Properties Penn Color Rabobank International Annie Rose Silver State Schools Credit Union Penn Medicine, Abramson Cancer Robert Rosen Mr. and Mrs. Gregory Silvers Center Radiology Alliance, PC 2017 ACKNOWLEDGEMENTS 17

Lauren Simmons Jessica Symens Union Bank & Trust Co WellHealth Quality Care Ira Simon TAS Foundation United Networks of America Marvin Wenger Gilbert Simonetti Ann Taylor United Way of San Antonio and Dayton Werner Kathy and Jim Simpson TCC Bexar County Westchester Triathlon Committee Sinkula Investments, Ltd. Tee Off Against Corporation UnitedHealthCare Mid-Atlantic Western Refining Siteman Kids Temple Hoyne Buell Foundation University Hospitals WGNA radio Skoda Contracting Tender Years, Inc. Child The University of Kansas Cancer Charles Wharton Center SL Green Development Centers Whelan Security Univision Management Company The Sleep Family Teneo Strategy WHM, LLC Urban Concrete Contractors, Ltd. Alisa and Sean Slovenski Tennessee Oncology Kelly Wiechman US Bank Douglas Smith Lee Tepper and Dorine Real Missy and Drew Wiedhorn US Bank National Association Jill Smith Terakeet, LLC Colleen and William Wildner US Mortgages Kristie Smith Texas Air Systems, LLC The William G. Pomeroy Foundation Beth and Natan Vaisman Maria Smith Texas Instruments, Inc. Carie Williams The Van Metre Family Foundation, Michael Smith Judy and Michael H. Thomas Tom Williams Inc. Sue and Mike Smith Thomas and Agnes Carvel Williams & Connolly, LLP Foundation Vanguard Charitable Endowment William Smith Willis Towers Watson Sarah Thompson Vantage Oncology, Inc. Patricia Snyder Patricia Willson Susan and John Thompson Mari Vasan So Long to Leukemia Judy and James Wilson Thompson & Knight, LLP. VCU Health System Jerome Solove Kendrick Wilson Thompson, Habib & Denison, Inc. The Vecellio Famly Foundation, Inc. Southeast Nebraska Cancer Center The Winkler Family Foundation Tilden-Coil Cares, Inc. Verywell (About) William Speakman Winnsboro Petroleum Company Tim and Sarah Jur Foundation Viacom Spectrum Pharmaceuticals Wisnoski Family Fund in memory of Tishman Speyer Properties, LP Lois Vick Carol and Mark Spisak Jackie Tito’s Handmade Vodka Katy Vickery Christina and H. Mark Sponseller Withum, Smith & Brown Tom & Virginia Jennaro Family The Victor E. and Caroline E. St. David’s HealthCare WIVB-TV, Channel 4/CW23 Foundation, Inc. Schutte Foundation - 1959 St. Mary’s Indian Orthodox Church Woodforest National Bank Tom Donaldson, Papa John’s Vidaris/LPI of Rockland The Woodlands Development The Tony and Cori Bates Family Vodaphone US, Inc. St. Thomas Orthodox Church of Company Fund Volkert, Inc. India, Houston World Bank Community Connection Tooley Oil Company VWR Charitable Foundation Gretchen Stangier Fund Total Wine and More The W. O’Neil Foundation, Inc. PA WRGB CBS6 TV Star Anesthesia, Dan Towriss John Wacker Patrick Starley Tonia Wurzelbacher Toyota of Gladstone Waffle House Foundation, Inc Barb and Tom Stayton yb-squared Transwestern Becky and Wade Walker SteelFab, Inc. – South Carolina Caroline Young TriAgile Warmenhoven Family Foundation David P. Steiner Young Hearts, Inc. Linda and Bob Trippel David Warren Sterne, Kessler, Goldstein & Fox Young Texans Against Cancer Paul Trotter and Elizabeth Neuman Sara Warren Kay and Davis Stewart Adelaide Zabriskie Truth North Warren G Bender Co. John Stilley Cathy and Scott Zeilinger Trust Company of the South Washington Gas Trevor Stokes The Zenith Insurance Company The Tsern Foundation The Washington Redskins The Stout Family Zotec Partners, LLC Kevin and Kristin Tu Washington University School of Strikes Against Cancer Joseph Zvesper Turner Construction Company Medicine Sub Pop Records Anonymous (27) Cal Turner, Jr. Waste Technology Services, Inc. Catherine Sullivan TurningPoint Global Solutions, LLC Wawanesa Insurance Deborah Sullivan Top Campaign U.S. Chamber Of Commerce Waxman Strategies Pam and Patrick Sullivan Fundraisers U.S. Coffee RE Doug Shindler WCAX TV Peace Sullivan UBS Financial Services, Inc. Visse Wedell Suntrust Bank ADF Companies - Pizza Hut UCHealth Wedell Foundation (Marsha Wedell) Suntrust Foundation Aetna Uhlig, LLC Wegman, Hessler & Vanderburg Swedish Medical Center All in for LLS Unanet The Weiler Foundation Swing Fore the Cure Sandy Allen-Bard Union Bank David Weinstein Jo Ann Swienton Nicole Ameduri Gonul Shari and Marc Weissbach 18 THE LEUKEMIA & LYMPHOMA SOCIETY

Amgen Amanda Brewer Discount Tire Timi Hallem Barbara Anderson Angie Brinkmeyer Chris Donahoo Tammi K. Hanak Jenny Anderson Katie Briscoe Mary Jo Doughtery Martha Handrich Andrew Dale & Team “No One Bristol-Myers Squibb Dow Brantley’s Campaign Team Joan Haratani Fights Alone” Brittany Rouse & Team Freedom Matt Doyle Michelle Harding Lorber Andrew Foley’s Campaign Team John Bunce Jonathan Duerr Adam Harris C.E. Andrews Adam Burck Emily Dumler Jessica Harrison Vicky Andritsch June Burke Amy Eberhardt Megan Hart Ann Street Elementary School Burlington Molly Egloff Kathy Hawkins Robert Annable Jayme Butcher Stephanie & Andy Eichberg Henry Jacobson & Team Michael Applebaum Amanda Butler-Eisenfeld Sally Ekus Suck-It-Cancer Alexis Areias, Ryan Fitzgerald & Jon Butts Moustafa El Hariry Heroes for Hazel Team ConCURE Cancer Caitlin Fitzgerald & Cross My Heart Elbit Systems of America Paul Hickman Rob Armstrong and Hope to Live Meghan Eller Tim Hodges At Home Dianne Callahan EY Zoe Holland August Robertson & Team Gus Bonnie Campagnuolo Katie Falk Tracy Howard Avella Specialty Pharmacy Cancer Crusaders Kevin Fay Katherine Hurd Mae Babbington Robert “Spider” Cantley Nicole Fink Thayer Hutcheson John Bacon David A. Caplan FIS In Memory of Rick Horstman Bank of Amerca Stephanie Carroll Kyle B. Fisher Jaime Orozco & Team Mickey Bank of Amerca Merrill Lynch Bill Carteaux Brooke Fitzgerald Luke Jaindl Banner MD Anderson Carter’s, Inc. Five & Alive Jakob Duchesneau & Team Brick Barclays Breakers Celgene Corporation Rebecca Foerster Barranco Family Maddie Jebavy Sammy Cemo Andrew Foley Michae Barry Jerry Maahs Memorial Golf Outing Karlee Cemo-McIntosh Clayton Forman Alexander Basse Jessica Johnson Keegan Chapman Patrick Foy, M.D. BD Jonathan Fields & Team Hope Charles Esten’s Team Addie Kyle Fritschi BDO Jonathan Gabay & The A-Team Nadia Christensen Erik Fromm Amy Beachy Jorge Rico and Team Jorge Strong Shar Christopher Mike Gebhardt Beat It Just Cure It Spencer Coker Hillary Gelfman Hallee Becher Just Cure the Damn Thing Melissa Coligan Genentech/Biogen Idec Ella Behnke Michelle Kadlacek Colton’s Armyv Neda Ghahremani Stacy Bennett, MD Betsy Katten Tim Connor Taki Gikakis Josh Bernstein Amanda Kay Robert Cornett Gila River Casinos Meg & Luke Bernstein Mallory Keating Ian Coyle Scott Gildea Wayne Berson Kelly Delaney, Ellie Strockis & Team Court Creeden Gilead The Beta Chapter of Sigma Alpha Kelly’s Cancer Killers Clay Covington & Team Redeem Sue Gilles Epsilon Curt Kersey Matt Cromar Global Franchise Group Barclay Bishop Kiven, Kotler, Lieberman, Fox, Joffe, Crushin’ Orange Go Team Trent Blackstone Goldschmidt & Kepes Ashley Curry Ali Goethel Rich Blaiklock Mason Klain Jennifer Curry John D. Goetz Sophie Blasberg John Klein Dan Cote & Team Pure4The Cure Goldman Sachs BloodType: Brooklyn Jared Kneitel Jana Davenport Tricia Gonyo Brad Blumenfeld Koppers J. Greg De Felice Jamie Graham BMC Chris Kostanecki Jason Dehaemers Michael Graham Leslie Bohl Robert Kottler Deloitte Eric Green Box Out Cancer KPMG Larissa DeMarco Greene Team Chase Bradley J.P. Kramer Joseph DeSabia Emery Greenwood Denise Bradley Annabel Krebs Tom DeTulleo Sophia Gregory R. Michael Brannock, Jr. Anthony Lallis Emily Dickinson Anthony Guadagnino Dow Brantley Dr. Larry’s Team Robert Dickinson Brianna Haag David Breen Molly Levine Dave DiLuigi Virginia Hall Alyssa Lewandowski 2017 ACKNOWLEDGEMENTS 19

Jason Liljenquist Kara Pancoast Ben Shapiro Team Sonia Paul Lilles Elizabeth Parry Virginia Sharitz Team Sunshine Daydream Jason Llewellyn Prina Patel Bill Shaw Team Survivin’ & Thrivin’ Al Lord Jessica Paulen Goldich Sheri Stewart / Defy the Verdict Team Twenty Amanda Lucero Connor Payne Ariel Shifter Team Western Digital Tood MacKay Sophia Peppas Rebecca Shope Team: Taylor Allen & Dakota Scott Madaus Matt Pepping Tommy Shriver Fauntleroy Karen Maginn Perfumania Vershalee Shukla, M.D. Terumo BCT Lois Markovich Nick Peterson Morgan Signora Teva Oncology Katie Martin Scott Peterson Alexandra Singer Mattie Thomas Valerie Fiordilino Maslow Grace Petty Kathy M. Slencak Scott Thorsteinson Kelly Masterson Pfizer Kirsten Smith, M.D. Tim Iorlano & Team Jack Sher Mathew Pharmacyclics/Janssen Ryan Snow Gary Trovato Matt Smith & Team Why We Fight Melissa & Mark Pietramale SoCalGas Megan Tsern Nicole Matthews Shane Polk Society Ties UCLA Health Tim McBride Praying for THE Ryan Melendez Teresa Spittle The United Food and Commercial Workers International Union (UFCW) Meghan McCann PVH Kirin Sran Madison Ugaz Chris & Gary McGraw PwC Shaylor Steele Clare Vanderbeek Amanda McHenry Ed Quinn Donald Steiner Clare Vanderbeek and Jack Morkan Mark McIntosh Gayle Coleman Rader Lillyana Stephanakis Craig Vanderwall, II McIntosh Family Ronnie Ram Stater Bros. Charities Ronnette Vondrak Julie McKenzie Rampart High School Stratford School - Fremont Campus VyStar Anne McLaughlin and Team Grant Amber Randolph Julia Strittmatter Walgreens Strong George Raptis Steven Sullivan Megan Walsh Mark McLaughlin Ravid Yosef & Married To The Cure Andrea Zalom Sutter and Team Live Walt Whitman High School Matt McNally McNab Reeves Love Doug Walter Ryan Melendez Mark Richards Sydney Clark, Jomsky & Team Panther Paws for a Cause Walter Johnson High School Nadine Mentor Ride-4-Ron Takeda Oncology Erica Warlick, MD Michael Milberg & Team 828 Riders of the Storm Team b.strong Washington Gas Shelley Miller River Oaks Elementary Team Believe Brian Waterman Mindy Miller Hill Charles Robbins Team Blumenfeld & Waterman Watertown Middle School Beatrice Miranda Julie Rogers Team Bright Side The WaWa Foundation Jessie Miranda Andy Roisman Team CUREageous Ashley Webster Missy’s Mojo Karen Rolland Team Deere in Memory of Bryant Jeff Weiner Rafael Mizrachi Carissa Rose Ante Wells Fargo Stephanie Mortitz Sondra Rose Team Driving Miss Carmen West Pharmaceuticals MWOY Leadership Team Circle of Allison Rosenthal, DO Hope Team Farewell No More Western Digital Kimberly Rost Shahin Naghavi Team For the Love of Aidan Western Refining Roswell High School NARS Team Generac Jennifer Wilkinson Luke Rutherford NewYork-Presbyterian & Weill Team Haley in Honor of Haley William Mason High School Salesforce Marston Cornell Medicine Alison Whelehan and Team Sandra Vander Wal and Team CURE Nick Ineck & Team Elevate Team It ALL Matters Campbell & Company Carmen Sans Graciaa Colin Nielson Team Jamie Adam Wilson Sarah Cannon/HealthONE NOVA Home Loans Team Javan Dwayne Wilson Stacy Schneeweis NuSkin Team Michael Nancy Wright Whatley Frances Schultz Lynne O’Brien Team OneinaPREMILlion Nate Wucherpfenning Michael Schultz Arden O’Connor Team Ride Brook Ahmed Zakari, MD Helena Scott Richard Ojeda Team Rise For a Cure Daniel Zausner Seattle Genetics Ryan Orton Team RonStrong F. Brooks Zeigler Hanna Sellinger P.J. O’Toole Team SDG&E/Sempra Zephyr Sheila Shah Aubry Padilla Team ShellBell Orli Zimmerman Kevin Shannahan Team SHINE 20 THE LEUKEMIA & LYMPHOMA SOCIETY

Legacy Circle

Legacy Circle honors those who Julia Cecil (in memory of Joyce Ann Doris Koch* Charles Reed* designate LLS as a beneficiary of Brewer) Edward Kramer (in memory of Dolores Rowland* their will, trust, retirement account Lawrence Cohen Connie Kramer) Stephen Sears or insurance policy, or fund a chari- Mary Jane Cumiford* Eduardo Maciel* Bruno and Irma Selmi* table gift annuity. We list our newest members below along with those Millard C. Davis* Jonathan and Henrietta Mandel* John J. Servinskas whose bequests of $10,000 or more Kathryn Dierks* Gregory Mahanna* Tom and Barb Stayton were received this year. Peggy and Margaret Dupaquier* Ruth Marcus* Bruce Swartz* James and Lynn Fager* Gloria Massari* Olga Tedeschi* Catherine Hunt Alspach Thomas Faria* Tina Matt* Thomas Thompson* Henry Acad* Robert Fitchen* Odell McCollum* Audrey Thornton* Joan Applebome (in memory of Robert Foster* Carolyn McGolerick* (in memory of Jeffrey Paul Baker) Robert Trusler* Anita Foster* Rev. James P. Daniel) Stephanie Arcel* Ernest Vander Molen* Grace Fram* Evelyn Wenzel Modrzewski* Edward Mitchell Badgett* Philip Warner* Blanche Goldstein* George and Rosemary Mojica (in Ralph Barone* Eunice Weed* memory of Oscar Rodriguez) Daniel Granahan* Patricia Bender (in memory of Abie Werth* Kyle Mostransky Joseph A. Dubuc) Eleanor Gray* Marna Wickesberg* Marilyn Pancoast (in memory of Joyce Benson* Lawrence Green* Chris Pancoast) Richard Windgassen* Roberta Berrey* F.E. Hardy* Rita Parodi* Catherine Woodfield* Patrick Bianchi* Dave and Shirley Hill (in memory of Kathleen Patrissi* Hal and Shirley Wright* Shirley Hill, RN) Mary L. Blair Michael and Gina Pavelec Anonymous (4) William F. Hoffman* Tom Boylan Stacia Peponis* * Deceased Stewart S. Johnson* Keith Brantley* Joan Persing (in memory of Harry Christopher Kearns Frank and Sue Brooks* Wujek, Jr. and in honor of John P. Mary Keegan (in memory of Nancy J. Mary Alice Brown* Persing) Montgomery) Helen Rainoff Howard and Betty Klausner

Research Portfolios

LLS Research Portfolios are groups Charitable Family Foundation and Niles Hushka, the Names Family Company, Megan’s Wing of research projects organized Arlene Schafer. Foundation and Sara Warren. Foundation, The Rhoda and David around a specific blood cancer Chase Family Foundation, Inc., interest. The list below includes Chronic Myelogenous Leukemia Aggressive Non-Hodgkin Team Bright Side, the Thomas and donors that generously invested Research Portfolio is funded in part Lymphoma Research Portfolio is Agnes Carvel Foundation, and the in a specific LLS research portfolio by Abbeville Family Partnership, funded in part by Donna Hartman, Wawa Foundation. during this fiscal year. Charles Godchaux - Charles Lisa Norcia and Barry Cheskin. Foundation, Becky Godchaux, Lymphoma Diagnostics Program Acute Lymphoblastic Leukemia Thomas McCarthy, and Leslie and Indolent Non-Hodgkin Lymphoma is funded in part by Chiyoko Research Portfolio is funded in part Larry Nance. Research Portfolio is funded in Furukawa. by Lisa Norcia and Barry Cheskin. part by the Dyer Family Foundation, Hodgkin Lymphoma Research Cristine and Timothy Lindenfelser, Mission Portfolio is funded in part Chronic Lymphocytic Leukemia Portfolio is funded in part by AM and Michael Smith. by Ping Y. Tai Foundation, Inc. Research Portfolio is funded in Charity Fund. part by the American Construction Pediatric and Young Adult Blood Patient Services Program is funded Company, the George L. Shields Myeloma and Waldenstrom Cancer Research Portfolio in part by CareFirst BlueCross Foundation, Inc., John Marten, Macroglobulinemia Research is funded in part by American BlueShield and the Gerald and Randy and Deborah Daniel Portfolio is funded in part by the Construction Company, EFESTĒ Paula McNichols Family Foundation. Carlson Family Foundation Inc., Franklin American Mortgage 2017 ACKNOWLEDGEMENTS 21

LIUNA Charitable Foundation Lang/Stiglitz Family Fund, the Mader the Hildegarde D. Becher Team b.strong, Tom and Virginia Specialized Center of Research is Foundation, The Orear Charitable Foundation, Inc., HM Insurance Jennaro Family Foundation, Inc., funded in part by The Jim Jacobs Foundation, Pharmacyclics, Stater Group, J.T. Tai & Co. Foundation, Beth and Natan Vaisman, the Wawa Charitable Foundation, the LIUNA Brothers, Subaru Pediatric Cancer Inc., Diana and Murray Johnson, the Foundation, West Endowment, Charitable Foundation, Angela and Foundation, and The W. O’Neil Kathryn Dent and John L. Tillman Brenda and James Wishbow, and Gary Trovato, and Cathy and Scott Foundation, Inc. Charitable Fund, Kayleen Larson Caroline Young. Zeilinger. Legacy Foundation, Mary Beth The Harry T. Mangurian, Jr. Beat and Christopher Kearns, John B. Therapy Acceleration Program is AML Project is funded in part Kellenyi, Emily and Neil Kishter, funded in part by the Carter Family by James Allen, The Altschul Lisa and Steven Kristel, The Kroll in loving memory of Jason, The Foundation, Timothy Babich, The Family Foundation, Paul Leinwand, Phase Foundation, and The Sence Boldt Family Philanthropy Fund, Lieblich Family Gift Fund, The Foundation. S. Lori Brown, Michael Capone, Lyon Family Foundation, Clyde S. the Carlton Family Foundation, McGregor and LeAnn Pedersen The Susan Lang Pay-It-Forward The Charles T. Bauer Charitable Pope, The Norcross Foundation, Inc. Transportation Assistance Foundation, Comier, Liz and In Memory of Herrick F. Norcorss, Program is funded in part by Michael Copley, Dhaval Dhru, Ed Jr. (Rick), Donald Porteous, Rahr the Abby Fund, Angel Wings & H. Pillsbury Foundation, F.M. Corporation, The Rogers Family Foundation, the Butler Family Kirby Foundation, Inc., Kristin and Foundation, The ROMA Foundation, Foundation, Capitol Federal John Hyland, The Jake Wetchler Pat and Jeff Sachs, Barb & Tom Foundation, the Dallas Foundation, Foundation, For Julie Foundation, Stayton, Donald Steiner, The the Enrichment Foundation, Forest Inc., Robert E. Gallagher Charitable Stephen Birnbaum Foundation, Pam County Potawatomi Foundation, the Trust, Cynthia and Frank Gasztonyi, and Patrick Sullivan, Peace Sullivan,

Endowment Funds

The Bill Beattie Memorial The Rachel Kudish Fund Endowment Fund (Alberta) Jane Elissa/Charlotte Meyers Mary & Robert Bronstein Memorial Endowment Fund Fund The Rae Endowment Fund (Ontario) The Virginia Major Brooks Memorial Vrushali Ranadive Fellowship Fund Endowment Fund Reich Endowment Fund de Villiers Endowment Fund The United Food and Commercial Thomas M. Ford Memorial Fund Workers (Canada) Endowment Fund GlaxoSmithKline Foundation - Gertrude B. Elion Endowment Fund GlaxoSmithKline, Inc. Research Fund Jim Jacobs Leukemia Research Fund 22 THE LEUKEMIA & LYMPHOMA SOCIETY

Leadership

National Board Renzo Canetta, MD Donald Proctor Danielle Gee Madison, CT Walnut Creek, CA Chief of Staff

Volunteers serve on our National Board of Directors providing lead- Scott A. Carroll, JD Steven T. Rosen, MD, FACP Kathy Griesenbeck ership and governance to help find Jackson Lewis City of Hope Interim Executive Vice President blood cancer cures. Cincinnati, OH Duarte, CA Chief Relationship Officer

Chairman of the Elizabeth J. (Betsy) Clark, PhD. Kenneth Schwartz Marcie Klein Board Saugerties, NY Ernst & Young, LLP Executive Vice President

Peter Brock New York, NY Chief Communications Officer Brock Development William S. Dalton, MD, PhD Palm Beach Gardens, FL M2Gen Bart Sichel Rosemarie Loffredo Tampa, FL Burlington Stores Executive Vice President Florence Township, NJ Chief Financial Officer Vice Chair Bernard H. Garil Jorge Benitez Delray Beach, FL Frank O. Smith, III, MD Gwen Nichols, MD Fort Lauderdale, FL Medpace Executive Vice President Francie Heller Cincinnati, OH Chief Medical Officer Secretary/Treasurer Heller Advisory New York, NY Kathryn C. Vecellio Tom Osgood Ralph E. Lawson, FHFMA, CPA The Vecellio Group Executive Vice President Baptist Health South Florida Richard M. Jeanneret Palm Beach, FL Chief Human Resources Officer Coral Gables, FL Ernst & Young LLP New York, NY Louise G. Warner Alice Rodd O’Rourke At Large Chagrin Falls, OH Executive Vice President Joseph B. Kelley Chief Development Officer

Raanan Horowitz Lilly USA, LLC Keith S. White Elbit Systems of America, LLC Washington, DC ParkerWhite Brand Interactive The Leukemia & Fort Worth, TX Cardiff by the Sea, CA Lymphoma Society of Michelle LeBeau, PhD Canada Board of University of Chicago Comprehensive Cancer Center Executive Shelagh Tippet-Fagyas Directors Chicago, IL Leadership President Canadian Operations James Beck Connie L. Lindsey The Leukemia & Hefren-Tillotson, Inc. Northern Trust Lymphoma Society Butler, PA Chicago, IL Offices Louis J. DeGennaro, PhD

William G. Behnke Kathleen Meriwether President & Chief Executive Officer United States: https://www.lls.org/ The Behnke Group Ernst & Young, LLP chapter-selection-page San Antonio, TX Philadelphia, PA Andrew S. Coccari Executive Vice President Canada: A. Dana Callow, Jr. Ted Moroz Chief Product Officer http://www.llscanada.org/ Boston Millennia Partners The Beer Store chapter-selection-page Boston, MA Ontario, Canada 2017 ACKNOWLEDGEMENTS 23 OUR MISSION Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

3 International Drive, Suite 200, Rye Brook, NY 10573 914.949.5213 www.lls.org Financials 2017 Annual Report

Table of Contents

PAGE 3 PAGE 4 PAGE 5 Independent Consolidated Consolidated Auditors’ Balance Sheet Statement of Report Activities

PAGE 6 PAGE 7 PAGE 8 Consolidated Consolidated Notes to Statement of Statement of Consolidated Functional Cash Flows Financial Expenses Statements 2 THE LEUKEMIA & LYMPHOMA SOCIETY 2017 FINANCIALS 3

Independent Auditors’ Report

The Board of Directors The Leukemia & Lymphoma Society, Inc.:

We have audited the accompanying reasonable assurance about whether the Opinion consolidated financial statements of consolidated financial statements are free In our opinion, the consolidated financial The Leukemia & Lymphoma Society, Inc. from material misstatement. statements referred to above present (LLS), which comprise the consolidated fairly, in all material respects, the financial An audit involves performing procedures balance sheet as of June 30, 2017, and position of The Leukemia & Lymphoma to obtain audit evidence about the the related consolidated statements of Society, Inc. as of June 30, 2017, and amounts and disclosures in the activities, functional expenses and cash the changes in its net assets and its consolidated financial statements. flows for the year then ended, and the cash flows for the year then ended in The procedures selected depend on related notes to the consolidated financial accordance with U.S. generally accepted the auditors’ judgment, including the statements. accounting principles. assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or Management’s Responsibility for the Report on Summarized Comparative error. In making those risk assessments, Consolidated Financial Statements Information the auditor considers internal control Management is responsible for the relevant to the organization’s preparation We have previously audited LLS’s preparation and fair presentation of and fair presentation of the consolidated consolidated financial statements, and these consolidated financial statements financial statements in order to design we expressed an unmodified opinion in accordance with U.S. generally audit procedures that are appropriate on those audited consolidated financial accepted accounting principles; this in the circumstances, but not for the statements in our report dated November includes the design, implementation, and purpose of expressing an opinion on the 2, 2016. In our opinion, the summarized maintenance of internal control relevant effectiveness of the organization’s internal comparative information presented herein to the preparation and fair presentation of control. Accordingly, we express no such as of and for the year ended June 30, consolidated financial statements that are opinion. An audit also includes evaluating 2016 is consistent, in all material respects, free from material misstatement, whether the appropriateness of accounting with the audited consolidated financial due to fraud or error. policies used and the reasonableness of statements from which it has been significant accounting estimates made by derived. Auditors’ Responsibility management, as well as evaluating the overall presentation of the consolidated Our responsibility is to express an financial statements. opinion on these consolidated financial statements based on our audit. We We believe that the audit evidence October 27, 2017 conducted our audit in accordance we have obtained is sufficient and with auditing standards generally appropriate to provide a basis for our accepted in the United States of audit opinion. America. Those standards require that we plan and perform the audit to obtain 4 THE LEUKEMIA & LYMPHOMA SOCIETY

THE LEUKEMIA & LYMPHOMA SOCIETY, INC. Consolidated Balance Sheet

June 30, 2017 Consolidated(with comparativeBalance amounts at June Sheet 30, 2016)

The Leukemia & Lymphoma Society, Inc. / June (In30, thousands) 2017 (with comparative amounts at June 30, 2016) (In thousands)

Assets 2017 2016

Cash and cash equivalents $ 41,401 18,596 Prepaid expenses and other assets 3,613 2,906 Contribution and other receivables, net (note 5) 17,785 17,244 Investments (note 3) 209,421 168,293 Fixed assets, net (note 8) 10,119 16,946

Total assets $ 282,339 223,985

Liabilities and Net Assets

Liabilities: Accounts payable and accrued expenses $ 21,711 13,655 Deferred revenue (note 6) 14,028 12,916 Awards and grants payable (note 2) 64,052 60,451 Co-Pay assistance payable (note 2) 20,071 13,469 Other long-term liabilities (note 9) 3,167 1,638

Total liabilities 123,029 102,129

Commitments and contingencies (notes 2 and 10)

Net assets (note 4): Unrestricted 126,993 84,178 Temporarily restricted 29,161 34,241 Permanently restricted 3,156 3,437

Total net assets 159,310 121,856

Total liabilities and net assets $ 282,339 223,985

See accompanying notes to consolidated financial statements. 2017 FINANCIALS 5

THE LEUKEMIA & LYMPHOMA SOCIETY, INC.

Consolidated Statement of Activities Consolidated StatementYear ended June 30, of 2017 Activities (with summarized totals for the year ended June 30, 2016)

The Leukemia & Lymphoma Society, Inc. / Year ended June(In thousands)30, 2017 (with summarized totals for the year ended June 30, 2016) (In thousands)

Temporarily Permanently Total Unrestricted restricted restricted 2017 2016

Operating revenue: Campaign contributions $ 237,443 21,077 5 258,525 258,839 Less direct donor benefit costs (25,955) ——(25,955) (26,348)

Net campaign contributions 211,488 21,077 5 232,570 232,491

Co-Pay contributions (note 2) — 77,779 — 77,779 46,379 Therapy acceleration program contractual return (note 1) 29,548—— 29,548 — Donated services, goods and media (note 7) 14,594 ——14,594 11,175 Legacies and other revenue 5,276 15 — 5,291 7,946 Service revenue 3,847 ——3,847 — Net interest and dividend income 2,730 136 — 2,866 1,352 Net assets released from restrictions (note 2): Co-Pay assistance 78,591 (78,591) ——— Satisfaction of other donor restrictions 26,426 (26,426) ———

Total operating revenue 372,500 (6,010) 5 366,495 299,343

Operating expenses (notes 7 and 11): Program services: Research 65,067 ——65,067 54,691 Patient and community service 125,677 ——125,677 89,209 Public health education 48,138 ——48,138 42,881 Professional education 21,698 ——21,698 15,373

Total program services 260,580 ——260,580 202,154

Supporting services: Management and general 29,049—— 29,049 27,553 Fund raising 47,656 ——47,656 44,749

Total supporting services 76,705 ——76,705 72,302

Total operating expenses 337,285 ——337,285 274,456

Change in net assets from operating activities 35,215 (6,010) 5 29,210 24,887

Foreign currency translation adjustment (180) (4) — (184) (110) Net increase (decrease) in fair value of investments (note 3) 7,780 648 — 8,428 (4,157)

Net assets transferred and reclassified — 286 (286) — 552

Change in net assets 42,815 (5,080) (281) 37,454 21,172

Net Assets: Beginning of year 84,178 34,241 3,437 121,856 100,684

End of year $ 126,993 29,161 3,156 159,310 121,856

See accompanying notes to consolidated financial statements. 6 THE LEUKEMIA & LYMPHOMA SOCIETY

Consolidated Statement of Functional Expenses

Year ended June 30, 2017 (with comparative totals for the year ended June 30, 2016)

Consolidated Statement of Functional(In thousands) Expenses The Leukemia & Lymphoma Society, Inc. / Year ended June 30, 2017 (with comparative totals for the year ended June 30, 2016) (In thousands)

Program Services Supporting Services Direct donor Patient and Public Management Total benefit costs community health Professional and Fund Research service education education Total general raising Total 2017 2016 2017 2016

Awards and grants (note 2) $ 42,219 42,219 42,219 40,011 Therapy acceleration program (note 2) 4,711 4,711 4,711 9,343 Clinical trial 2,142 2,142 2,142 Financial aid to patients 1,703 1,703 1,703 1,299 Co-Pay assistance (note 2) 72,969 72,969 72,969 40,030 Co-Pay processing fees 4,595 4,595 4,595 3,375 Donated services, goods and media (note 7) 4,021 2,563 4,095 245 10,924 279 3,391 3,670 14,594 11,175 Salaries and employee benefits and taxes (note 9) 5,840 25,488 24,124 12,572 68,024 16,212 17,466 33,678 101,702 90,623 Professional fees 2,946 3,891 4,798 2,473 14,108 3,580 5,019 8,599 22,707 18,658 3,305 1,725 Printing, advertising, and supplies 97 3,489 3,819 1,292 8,697 2,166 6,718 8,884 17,581 16,794 5,090 5,052 Occupancy, telephone and insurance (note 10) 367 3,174 2,882 1,186 7,609 1,719 2,583 4,302 11,911 11,863 Travel and meetings 817 2,056 2,329 1,625 6,827 1,854 1,485 3,339 10,166 7,482 14,877 13,672 Equipment rentals and maintenance 1,109 1,256 1,209 689 4,263 1,032 1,021 2,053 6,316 4,828 Postage and shipping 17 1,309 1,878 362 3,566 390 2,624 3,014 6,580 7,302 Miscellaneous 170 1,233 1,026 556 2,985 689 701 1,390 4,375 5,223 2,683 5,899 Impairment of fixed assets (note 8) 5,434 5,434 5,434 Depreciation and amortization 611 1,951 1,978 698 5,238 1,128 1,214 2,342 7,580 6,450

Total expenses $ 65,067 125,677 48,138 21,698 260,580 29,049 47,656 76,705 337,285 274,456 25,955 26,348

See accompanying notes to consolidated financial statements. 2017 FINANCIALS 7

THE LEUKEMIA & LYMPHOMA SOCIETY, INC.

Consolidated Statement of Cash Flows Consolidated Statement of Cash Flows Year ended June 30, 2017 (with comparative amounts for the year ended June 30, 2016) (In thousands) The Leukemia & Lymphoma Society, Inc. / Year ended June 30, 2017 (with comparative amounts for the year ended June 30, 2016) (In thousands)

2017 2016

Cash flows from operating activities: Change in net assets $ 37,454 21,172 Adjustments to reconcile change in net assets to net cash provided by operating activities: Net (increase) decrease in fair value of investments (8,428) 4,157 Impairment of fixed assets 5,434 Depreciation and amortization 7,580 6,450 Provision for uncollectible accounts 188 (445) Changes in operating assets and liabilities: Prepaid expenses and other assets (707) 3,143 Contributions and other receivables (729) (7,810) Accounts payable and accrued expenses 8,056 (3,320) Other long-term liabilities 1,529 197 Deferred revenue 1,112 (4,886) Awards and grants payable 3,601 (8,884) Co-Pay assistance payable 6,602 (996)

Net cash provided by operating activities 61,692 8,778

Cash flows from investing activities: Purchases of fixed assets (6,187) (8,570) Purchases of long-term investments (117,279) (238,736) Sales of investments 84,579 204,227

Net cash used in investing activities (38,887) (43,079)

Net increase (decrease) in cash and cash equivalents 22,805 (34,301)

Cash and cash equivalents at beginning of year 18,596 52,897

Cash and cash equivalents at end of year $ 41,401 18,596

See accompanying notes to consolidated financial statements. 8 THE LEUKEMIA & LYMPHOMA SOCIETY

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

1) Organization and Summary of Significant Accounting Policies

A) Organization The Leukemia & Lymphoma Society, Inc. (LLS) is the world’s largest voluntary health agency dedicated to finding cures for blood cancers and providing services to blood cancer patients, their families, and caregivers. LLS’s mission is to cure leukemia, lymphoma, Hodgkin’s disease, and myeloma and improve the quality of life of patients and their families. LLS research grants have funded many of today’s most promising advances for the treatment of blood cancer patients, including targeted therapies and immunotherapies. LLS is a leading source of publicly available information regarding blood cancer, and education and support programs. LLS influences public policies that accelerate the development and approval of new blood cancer therapies and advocates for all blood cancer patients and their families, helping patients navigate their cancer treatments and access to quality, affordable and coordinated care. LLS is dedicated to removing barriers to care by representing the healthcare and medical research interests of patients and families to policy makers at all levels of government.

B) Principles of Consolidation The accompanying consolidated financial statements include the accounts of LLS that encompass the National Office of LLS and its fifty-six chapters in the United States, and LLS’s not-for-profit affiliates, including The Leukemia & Lymphoma Society of Canada, Inc. (LLSC) and its five chapters in Canada, The Leukemia & Lymphoma Society Research Programs, Inc. (LLSRP), The Leukemia & Lymphoma Society Research Foundation (LLSRF), Beat AML, LLC (BAML) and PearlPoint Cancer Support, Inc. (PPCS). Effective March 28, 2016, LLS became the sole member of PPCS. As part of the assumption of control, LLS recognized a transfer of net assets of $552. All significant inter- company and intra-LLS accounts and transactions have been eliminated in consolidation.

C) Tax-Exempt Status LLS, LLSRP, LLSRF and PPCS qualify as charitable organizations as defined by Internal Revenue Code Section 501(c)(3) and, accordingly, are exempt from federal income taxes under Internal Revenue Code Section 501(a). Additionally, since these organizations are publicly supported, contributions qualify for the maxi- mum charitable contribution deduction under the Internal Revenue Code. LLSC is registered as a charitable organization under the Income Tax Act (Canada) and is, therefore, not subject to income taxes if certain disbursement requirements are met. BAML is a single-member limited liability company and is a disregarded pass-through entity. Accordingly, all revenue and expenses are included in LLS. Income of BAML is exempt from federal income taxes under Internal Revenue Code Section 501(c)(3) consistent with LLS. LLS and PPCS recognize the effect of income tax positions only if those tax positions are more likely than not to be sustained. Income generated from activities unrelated to exempt purposes are subject to tax under Internal Revenue Code Section 511. There were no entities that recognized any unrelated business income tax liability for the years ended June 30, 2017 and 2016.

D) Estimates The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires LLS’s management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The significant estimates made in the preparation of these consolidated financial statements include the fair value of alternative investments, allowance for uncollect- ible accounts, allocation of expenses, and valuation of donated goods, services and media. Actual results could differ from those estimates.

(continues ») 2017 FINANCIALS 9

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

E) Risks and Uncertainties LLS invests in various investment securities. Investment securities are exposed to various risks such as interest rate risks, fluctuations in market values, and credit risks. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the consolidated balance sheet. LLS’s principal source of revenue is contributions by the general public. Accordingly, LLS’s operations are depen- dent upon individual contributions, that are affected by general economic conditions, employment levels, and other factors over which LLS has little or no control. By contrast to the granularity of the general public donations, the Co-Pay program in 2017 and 2016 was funded by eight and nine donors, respectively. In addition, the Beat AML Master Trial was primarily funded by five donors in 2017.

F) Summarized Financial Information The consolidated financial statements are presented with 2016 summarized or comparative information. With respect to the consolidated statement of activities, such prior year information is not presented by net asset class and, in the consolidated statement of functional expenses, 2016 expenses by object are presented in total rather than by functional category. Accordingly, such information should be read in conjunction with LLS’s 2016 consoli- dated financial statements from which the summarized information was derived.

G) Subsequent Events LLS evaluated subsequent events after the balance sheet date of June 30, 2017 through October 27, 2017, which was the date the consolidated financial statements were issued, and concluded that no additional disclosures are required.

H) Net Asset Classifications To ensure observance of limitations and restrictions placed on the use of resources available to LLS, funds that have similar characteristics have been classified into three net asset categories as follows: Unrestricted net assets: Consist of funds that are fully available, at the discretion of LLS’s Board of Directors, for LLS to utilize in any of its programs or supporting services. Temporarily restricted net assets: Consist of funds that are restricted by donors for a specific time period and/or purpose. Permanently restricted net assets: Consist of funds that contain donorimposed restrictions requiring that the principal be invested in perpetuity. Income earned on these funds is recorded as temporarily restricted net assets and is released from restriction when the donor stipulated purpose has been fulfilled and/or the amount has been appropriated in compliance with the Board-approved spending policy (note 4).

I) Foreign Currency Translation LLSC uses the Canadian dollar as its functional currency. Accordingly, the currency translation of the financial statements of LLSC to U.S. dollars is included as a translation adjustment in the consolidated statement of activities.

J) Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The three levels of the fair value hierarchy are as follows:

Level 1 inputs are quoted or published prices (unadjusted) in active markets for identical assets or liabilities that a reporting entity has the ability to access at the measurement date.

(continues ») 10 THE LEUKEMIA & LYMPHOMA SOCIETY

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

Level 2 inputs other than quoted or published prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 unobservable inputs for the asset or liability.

LLS follows the provisions of Accounting Standards Codification (ASC) 820, Fair Value Measurement, for its alter- native investments that do not have readily determinable fair values, including hedge funds, limited partnerships, and other funds. This guidance allows, as a practical expedient, for the estimation of the fair value of investments in investment companies for which the investment does not have a readily determinable fair value, using net asset value (NAV) per share or its equivalent, as reported by the investment managers. The classification of investments in the fair value hierarchy is not necessarily an indication of the risks, liquidity, or degree of difficulty in estimating the fair value of each investment’s underlying assets and liabilities.

K) Contributions, Grants and Deferred Revenue Contributions are recorded as revenue, at their fair value, when received or promised unconditionally. Contributions received with donor restrictions that limit their use are reported as either temporarily or permanently restricted revenue. When a donor restriction is met through the passage of time or fulfillment of a purpose restric- tion, temporarily restricted net assets are reclassified to unrestricted net assets and reported in the consolidated statement of activities as net assets released from restrictions. Conditional contributions are recognized as reve- nue when the conditions have been substantially met. Certain grants are accounted for as exchange transactions whereby revenue is recognized when the related expenses are incurred. Amounts received under these arrange- ments but not yet expended are reported as deferred revenue.

L) Therapy Acceleration Program Contractual Return In January 2009, as part of its Therapy Acceleration Program (TAP), LLS entered into an agreement with Celator Pharmaceuticals, Inc. (Celator) through which LLS provided funding of approximately $4,100 to Celator in support of the Phase 2 study of Celator’s lead compound Vyxeos™ (daunorubicin and cytarabine liposome for injection) for the treatment of Acute Myeloid Leukemia (AML). From 2012 through 2016, LLS provided funding of an additional $5,000 for the Phase 3 clinical study of Vyxeos™. LLS provisions of funding to Celator were based on clinical milestones. As part of the agreement, Celator was obligated to make payments to LLS relative to the timing of the product commercialization and other liquidity events. In July 2016, Jazz Pharmaceuticals (Jazz) completed the purchase of Celator, triggering a payment of $13,716 to LLS. In late 2016, Jazz terminated the agreement with LLS triggering a onetime contract termination fee of $11,612 to eliminate potential future royalty payments related to Vyxeos™. The total amount of the return to LLS from its TAP investment in Celator was $25,328. The remaining $4,220 of TAP contractual return comes from various other TAP investments.

M) Service Revenue Service revenue is accounted for as an exchange transaction whereby revenue is recognized when the related expenses are incurred. Amounts received under these arrangements but not yet expended are reported as deferred revenue.

N) Donated Goods and Services LLS has determined that certain of the donated goods and services it receives meet the criteria for recognition in the consolidated financial statements. The value of contributed goods was determined based on fair market value estimates. The value of contributed services was determined for volunteers that possess specialized skills, and would otherwise need to be purchased. These goods and services are recognized as revenue and expense (note 7).

(continues ») 2017 FINANCIALS 11

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

O) Donated Media LLS has conducted national public service announcements (PSA) media campaigns and benefited from donated media time that was aired on television and radio. The value of contributed media, which is recognized in the consolidated financial statements, was estimated based on the placement, audience, and demographics of the PSA’s (note 7).

P) Cash Equivalents Cash equivalents consist of short-term investments with an original maturity of three months or less from date of purchase, except for amounts held in investments.

Q) Investments Investments are stated at fair value based upon quoted or published market prices, except for the fair values of alternative investments which are based on NAVs provided by the fund managers or general partners, based upon the underlying net assets of the funds consistent with the concepts of ASC 820. These values are reviewed and evaluated by management.

R) Fixed Assets and Depreciation Fixed assets, which consist principally of equipment, software, and leasehold improvements, are recorded at cost, and are depreciated or amortized using the straight-line method over the estimated useful lives of the assets or the terms of the leases, if shorter, ranging 2 to 10 years (leasehold improvements 7 years; furniture, fixtures, and office equipment 7 to 10 years, and computer equipment and software 2 to 5 years).

S) Other Long-Term Liabilities Other long-term liabilities represent LLS’s liability for the Internal Revenue Code Section 457 deferred compensa- tion plans recorded at fair market value (note 9) and straight-line rent of office leases (note 10).

T) Professional Fees Professional fees included in the consolidated financial statements principally include professional fundraising fees, contracted software development, and legal and auditing fees.

U) Reclassifications Certain reclassifications of 2016 amounts have been made to conform to the 2017 presentation.

2) Research and Co-Pay Assistance Program

LLS has various activities that are utilized to carry out its mission as presented below:

Research Awards and Grants: Awards and grants for research are approved by LLS’s Board of Directors and are recognized as expense when contractual conditions have been satisfied. The budgets for multi-year grants, which are generally two to five years in length, are approved on an annual basis and may be terminated at the discretion of LLS’s Board of Directors. LLS has multi-year grant commitments of $45,410 at June 30, 2017, which are conditioned upon future events and, accordingly, are not recorded. LLS has unconditional grants payable of $64,052 and $60,451 at June 30, 2017 and 2016, respectively, which are anticipated to be paid in the next year. Grant refunds of approximately $923 and $450 as of June 30, 2017 and 2016, respectively, have been netted against awards and grants expense.

(continues ») 12 THE LEUKEMIA & LYMPHOMA SOCIETY

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

TAP: TAP is LLS’s strategic initiative to speed the development of blood cancer treatments and supportive diagnostics by creating business alliances with biotechnology and pharmaceutical companies. TAP provides funding for investiga- tional new drug enabling studies and clinical-stage projects. TAP contracts are recognized as an expense in the year program milestones are achieved. Multi-year contracts, which are generally two to three years in length, are reviewed against milestones on a quarterly basis and may be terminated at the discretion of LLS’s Board of Directors. LLS has contract commitments of $9,144 and $10,214 at June 30, 2017 and 2016, respectively, that are conditioned upon future events and, accordingly, are not recorded. Commitments for the awards and grants and TAP programs are contingent upon the satisfactory completion of mile- stones and/or other conditions in the grant and contract agreements. If such conditions are satisfied, the amounts are estimated to be paid as follows:

Year ending June 30: 2018 $ 28,702 2019 19,101 2020 and thereafter 6,751

Total $ 54,554

Co-Pay Assistance Program Co-Pay Assistance Program: The Co-Pay Assistance program offers financial assistance to patients in meeting their insurance Co-Pay obligations for prescription medications or private/public health insurance premiums. Amounts awarded under the program are expensed in the year approved based on the available funding in the program. Revenue is recognized when the grants are received while expenses are recognized as patients are approved for par- ticipation according to program criteria. The Co-Pay Assistance payable of $20,071 and $13,469 has been established based on approved patient applications received through June 30, 2017 and 2016, respectively. At June 30, 2017, temporarily restricted net assets include $8,148 received in 2017, which are available for expenditure and are intended to be awarded in fiscal 2018. The following summarizes the activities of the Co-Pay Assistance program in 2017 and 2016.

2017 2016

Beginning balance $ 8,960 7,254 Co-Pay contributions 77,779 46,379 Amount expended during the year: Direct assistance to patients (72,969) (40,030) Other expenses incurred and reimbursed under the contract (5,622) (4,643)

Amounts available for expenditures in the next year $ 8,148 8,960

(continues ») 2017 FINANCIALS 13

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

3) Investments

The following tables present LLS’s fair value hierarchy of investments measured at fair value on an annual basis as of June 30, 2017 and 2016:

2017 Level 1 Level 2 Level 3

Money market funds and cash $ 63,155 63,155 Fixed income: Corporate bonds 49,312 49,312 Government securities and other 2,098 2,098 Equities: Large cap equity 32,356 32,356 International equity 30,261 30,261 Small/mid cap equity 20,813 20,813 Commodities 3,566 3,566

201,561 $ 201,561

Investments reported at net asset value: Multi strategy hedge funds 7,860

Total investments reported at net asset value 7,860

$ 209,421

2016 Level 1 Level 2 Level 3

Money market funds and cash $ 58,704 58,704—— Fixed income: Corporate bonds 36,228 36,228—— Government securities and other 2,032 2,032 —— Equities: Large cap equity 22,466 22,466—— International equity 20,406 20,406—— Small/mid cap equity 10,429 10,429—— Real estate 5,293 5,293—— Commodities 2,996 2,996——

158,554 $ 158,554——

Investments reported at net asset value: Multi strategy hedge funds 7,503 Long/short equities 2,236

Total investments reported at net asset value 9,739 $ 168,293

(continues ») 14 THE LEUKEMIA & LYMPHOMA SOCIETY

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

In 2016, LLS transitioned from a traditional Investment custodian to an Outsourced Chief Investment Officer. In this process, LLS liquidated its investment portfolio and reinvested all funds. Investment expenses totaled $376 and $560 for the years ended June 30, 2017 and 2016, respectively. The unreal- ized gains were $4,504 and $3,513 for the years ended June 30, 2017 and 2016, respectively. LLS’s alternative investments are diversified across two investment strategies, as follows: 1. Multi strategy hedge funds – represent investments in a broad range of investment strategies that seek to exploit opportunities as they occur in the markets due to temporary dislocations or structural inefficiencies and include event-driven strategies, distressed debt, merger and other arbitrage, and value investing. 2. Long/short equities – primarily investments in funds that, in turn, invest in liquid, marketable securities, attempting to realize gains through the identification of mispriced securities. These strategies create indirect exposure to LLS through short sales of securities, trading in future and forward con- tracts, and other derivative products. Derivatives are investment contracts used to hedge risk. While these financial instruments may contain varying degrees of risk, LLS’s risk with respect to such transactions is limited to its capital balance in each investment. LLS’s alternative investments contain various redemption restrictions with required written notice ranging from 45–95 days. By contrast, all of LLS’s nonalternative investments are highly liquid and can be redeemed daily without restriction. As of June 30, 2017 and 2016, the following table summarizes the redemption provisions for those invest- ments reported at NAV:

2017 2016

Redemption period: Quarterly $ 6,265 6,003 Annual 1,595 3,736

Total $ 7,860 9,739

As of June 30, 2017 and 2016, LLS had no unfunded commitments on its alternative investments.

4) Temporarily and Permanently Restricted Net Assets

Temporarily restricted net assets and the income earned on permanently restricted net assets are available for the following purposes at June 30, 2017 and 2016:

2017 2016 Temporarily Permanently Temporarily Permanently restricted restricted restricted restricted

Time restrictions $ 6,297 — 272 — Research 7,097 3,035 19,377 3,280 Patient service 7,533 — 5,367 — Co-Pay assistance 8,148 — 8,960 — Other 86 121 265 157

Total $ 29,161 3,156 34,241 3,437

(continues ») 2017 FINANCIALS 15

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

LLS follows the provisions of the New York Prudent Management of Institutional Funds Act, which imposes guidelines on the management and investment of endowment funds. LLS has interpreted the relevant law as allowing LLS to appropriate for expenditure or accumulate so much of an endowment fund as LLS determines is prudent considering the uses, benefits, purposes, and duration for which the endowment fund is established, subject to the intent of the donor as expressed in the gift instrument. LLS has adopted investment and spending policies for endowment assets that attempt to provide a predictable stream of funding to programs supported by its endowment funds while seeking to protect the original value of the gift. The spending rate policy at June 30, 2017 and 2016 was 4%, plus any additional amounts advised by donors. Under this policy, the endowment assets are invested in a manner that is intended to produce results consistent with LLS’s overall investment strategy. The following table presents changes in the donorrestricted endowment funds for the year ended June 30, 2017:

Temporarily Permanently restricted restricted Total

Endowment net assets at July 1 $ 2,962 3,437 6,399 Investment income 428 — 428 Net appreciation 335 — 335 Contributions —55 Reclassifications (347) (286) (633) Appropriation for expenditure (252) — (252)

Endowment net assets at June 30 $ 3,126 3,156 6,282

The following table presents changes in the donor-restricted endowment funds for the year ended June 30, 2016:

Temporarily Permanently restricted restricted Total

Endowment net assets at July 1$3,086 3,690 6,776 Investment (loss) income (164) 64 (100) Net appreciation 280 — 280 Reclassifications — (277) (277) Appropriation for expenditure (240) (40) (280)

Endowment net assets at June 30 $ 2,962 3,437 6,399

(continues ») 16 THE LEUKEMIA & LYMPHOMA SOCIETY

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

5) Contribution and Other Receivables

LLS’s contribution and other receivables at June 30, 2017 and 2016 consist of unconditional promises to give, receiv- ables associated with service revenue, and legacies for which the underlying wills have been declared valid by the probate court and no other conditions are required to be met. Contributions and other receivables consist of the following:

2017 2016

Campaign contributions $ 2,749 4,248 Co-Pay contributions 6,000 6,450 Other restricted contributions 8,080 6,546 Service revenue and other 956 —

Total $ 17,785 17,244

Contributions receivables are originally recorded based on discounted cash flows using a risk adjusted discount rate. Amounts are scheduled to be received as follows:

2017 2016

Less than one year $ 13,688 10,723 1 to 5 years 5,186 7,272 After 5 years 25 50

Subtotal 18,899 18,045

Less: Allowance for uncollectible accounts (357) (169) Discount to present value (1.5% to 5.0%) (757) (632)

Total $ 17,785 17,244

As of June 30, 2017 and 2016, 53% and 65% of gross legacies and contributions receivable were from two funding sources.

(continues ») 2017 FINANCIALS 17

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

6) Deferred Revenue

The majority of deferred revenue includes amounts received for special events that will be held subsequent to the fiscal year end. Deferred revenue as of June 30, 2017 and 2016 consists of the following:

2017 2016

Grants $45 1,145 Service revenue 2,100 — Special events 11,883 11,771

Total $ 14,028 12,916

7) Donated Goods, Services and Media

The value of donated goods, donated services for family support group facilitators and research grant reviewers, as well as donated media are included in both revenue and expense as shown below:

2017 2016

Donated goods $ 3,552 — Donated services 2,430 2,867 Donated media 8,612 8,308

Total $ 14,594 11,175

8) Fixed Assets, Net

Fixed assets at June 30, 2017 and 2016 consist of the following (in thousands):

2017 2016

Leasehold improvements $ 1,795 1,434 Furniture, fixtures, and other oce equipment 3,547 3,397 Computer equipment and software 36,350 39,706

Total 41,692 44,537

Less accumulated depreciation and amortization (31,573) (27,591)

Fixed assets, net $ 10,119 16,946

In 2017, an impairment of fixed assets of $5,434 was recorded for the write-off a fund-raising platform that will no longer be utilized by LLS.

(continues ») 18 THE LEUKEMIA & LYMPHOMA SOCIETY

Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. / June 30, 2017 (Amounts in thousands)

9) Retirement Plans

LLS has a defined contribution 403(b) plan covering all employees meeting age and service requirements. LLS contri- butions are based on a percentage of each eligible employee’s salary and years of service. Expenses under this plan aggregated $2,149 and $1,827 for the years ended June 30, 2017 and 2016, respectively. LLS has nonqualified deferred compensation plans for its executive staff subject to the provisions of the Internal Revenue Code Section 457 (the 457 Plans). There were no expenses incurred for the years ended June 30, 2017 and 2016. The assets of the 457 Plans are included in investments in the accompanying consolidated balance sheet and amounted to approximately $1,574 and $1,405 at June 30, 2017 and 2016, respectively. The liabilities of the 457 Plans are included in other long-term liabilities in the accompanying consolidated balance sheet and amounted to approxi- mately $1,574 and $1,374 at June 30, 2017 and 2016, respectively.

10) Lease Commitments

The leases for premises, which LLS’s National Office and chapters occupy, expire on various dates through March 31, 2031, and provide for certain payments subject to escalation and periodic rate increases relating to real estate taxes, operating expenses, and utilities. The approximate minimum aggregate future annual rental commitments are summarized as follows:

Year ending June 30: 2018 $ 7,106 2019 6,134 2020 5,636 2021 5,243 2022 4,477 Thereafter 13,923

Total $ 42,519

11) Joint Costs Allocation

For the years ended June 30, 2017 and 2016, LLS incurred expenses to conduct activities that had both fundraising appeals as well as mission program and management and general components (joint activities). Those joint activities included direct mail, coinboards, and media campaigns. Such costs are allocated based on applicable accounting standards and were allocated as follows:

2017 2016

Fund raising $ 12,832 13,901 Patient and community service 2,666 2,076 Public health education 5,002 5,117

Total $ 20,500 21,094

OUR MISSION Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

3 International Drive, Suite 200, Rye Brook, NY 10573 914.949.5213 www.lls.org